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ABSTRACT 
 Interacting cellular systems with nano-interfaces has shown great promise in 
promoting differentiation, regeneration, and stimulation. Functionalized nanostructures 
can serve as topological cues to mimic the extracellular matrix network to support cellular 
growth. Nanostructures can also generate signals, such as thermal, electrical, and 
mechanical stimulus, to trigger cellular stimulation. At this stage, the main challenges of 
applying nanostructures with biological systems are: (1) how to mimic the hierarchical 
structure of the ECM network in a 3D format and (2) how to improve the efficiency of the 
nanostructures while decreasing its invasiveness.  
 To enable functional neuron regeneration after injuries, we have developed a 2D 
nanoladder scaffold, composed of micron size fibers and nanoscale protrusions, to mimic 
the ECM in the spinal cord. We have demonstrated that directional guidance during 
neuronal regeneration is critical for functional reconnection. We further transferred the 
nanoladder pattern onto biocompatible silk films. We established a self-folding strategy to 
fabricate 3D silk rolls, which is an even closer system to mimic the ECM of the spinal cord. 
As demonstrated by in vitro and in vivo experiments, such a scaffold can serve as a grafting 
bridge to guide axonal regeneration to desired targets for functional reconnection after 
spinal cord injuries. Benefited from the robust self-folding techniques, silk rolls can also 
	
	 viii 
be used for heterogeneous cell culture, providing a potential therapeutic approach for 
multiple tissue regeneration directions, such as bones, muscles, and tendons. 
 For achieving neurostimulation, we have developed photoacoustic nanotransducers 
(PANs), which generate ultrasound upon excitation of NIR II nanosecond laser light. By 
surface functionalize PAN to bind to neurons, we have achieved an optoacoustic neuron 
stimulation process with a high spatial and temporal resolution, proved by in-vitro and in-
vivo experiments. Such an application can enable non-invasive, optogenetics free and MRI 
compatible neurostimulation, which provides a new direction of gene-transfection free 
neuromodulation.  
 Collectively, in this thesis, we have developed two systems to promote functional 
regeneration after injuries and stimulate neurons in a minimally invasive manner. By 
integrating those two functions, a potential new generation of the bioengineered scaffold 
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CHAPTER 1: Introduction 
1.1 Motivation  
With the rapid development of nanotechnologies, there are increasing interests in 
applying nanomaterials as innovative options for biological and biomedical applications. 
Nanomaterials are featured in their decreased size, increased surface-area-to-volume ratio, 
increased solubility, and functional surface composition, which makes nanomaterial an 
exciting addition to the biotechnology field [1-3]. The current state of the research includes 
using nanomaterials mainly in imaging contrast agents, drug delivery vehicles, as well as 
therapeutic applications. Unfortunately, these applications are still limited in passively 
support or monitor biological activities.  
As researchers continue to uncover functional properties of nanomaterials, in recent 
years, nanomaterials have been widely developed with functions to generate topographical, 
chemical, electrical, thermal, and biomechanical signals [4-6]. Deploying nanostructures to 
interface with biological systems provides a unique approach to actively regulate and 
modulate cellular behaviors, which is tremendously different from the traditional passive 
way. Therefore, how to develop a novel nano-bio interface to achieve cell modulation is 
becoming an emerging topic for the current renovation of nanotechnology.  
As shown in Figure 1.1, nanostructures in different dimensions have been used to form 
the nano-bio interfaces. Nanoparticles and nanorods are considered as zero-dimensional 
(0D) nanostructures, while nanowires and nanotubes are called as one-dimensional (1D) 




nanomaterials can go through the endocytosis pathway to directly interface with cells. 
Signals generated on the surface of the 0D and 1D nanomaterials can locally induce 
behavioral changes in the cellular systems. For example, the photothermal effect produced 
by gold nanoparticles and nanorods has been used to cause the apoptosis of cancer cells [7-
11]. These photothermal signals are also proven to be capable of stimulating neuronal cells 
[12-14]. Two-dimensional (2D) nano-features have been broadly developed as topological 
surface cues to regulate the growth pattern of cells. Various cellular systems have been 
cultured on the 2D nano-features, and positive impact has been demonstrated to show 
effective regulation in promoting local attachment of the cells, which potentially trigger 
the outgrowth, regeneration, and differentiation of these cell types [15-17]. Three-
dimensional (3D) nanocomposites have been designed as devices for specific biological 
applications. Functional nanomaterials have been coupled into devices, aiming to explore 
the potential to move nanomaterials from bench-top to clinical use [18-19].  
 




However, among all the nano-bio interfaces, there is still a need to improve efficiency, 
reduced the side effect, cytotoxicity, and invasiveness of current systems. Also, due to the 
rapid development of tissue engineering in modulating cellular behaviors in multiple 
biological systems, new nano-features with novel material and structural design are needed 
to meet different requirements in the complex tissue environment.  
To sum up, in this dissertation, I’m focusing on developing new nano-bio interfaces to 
modulate three cellular behaviors: regeneration, differentiation, and stimulation. The 
reason why these cell modulation processes are chosen here is that that they are closely 
relevant to the disease models of spinal cord injury (SCI), nerve, and bone regeneration, 
together with neurological disorders, respectively. Therefore, in the following sections, I 
will talk about a brief biological mechanism, up-to-dated technologies, and how nano-bio 
interfaces are applied for each cell modulation process.  
 
1.2 Overview of cell modulation  
Cell modulation underlies the flexibility of operating cellular behaviors. The individual 
cellular modulator can have divergent actions in cells by targeting multiple physiological 
mechanisms and activities [20].  
1.2.1 Regeneration 
Neuron regeneration is a complex process, differs from the injured location. In the 
peripheral nervous systems (PNS), regeneration can happen when the gap size is small, 




suture the injured nerves together, or to transfer a nerve graft from elsewhere in the body 
[22]. For the injuries in the CNS, unfortunately, a solution to completely repair SCI has not 
been found, which is due to the formation of the inhibitory environment to retard the 
regeneration.  
In the CNS, the spinal cord is composed of the cervical, thoracic, lumbar, sacral, and 
coccygeal spinal regions (Figure 1.2a) [23]. A butterfly-shaped region, located on the center 
of the spinal cord, is referred to as gray matter, which contains cell bodies of excitatory 
neurons, as well as glial cells and blood vessels. The gray matter is surrounded by white 
matter, which helps to protect and insulate the spinal cord. White matter consists of axons 
and glial cells, including oligodendrocytes, astrocytes, and microglia. Oligodendrocytes 
myelinate the axons in the CNS, astrocytes contribute as a blood-nerve barrier, while 
microglia are the immune cell.  
After injuries in the CNS (Figure 1.2b), the primary mechanical trauma causes 
necrosis, edema, hemorrhage, and vasospasm. The secondary pathophysiological 
mechanism induces apoptosis, fluid disturbance, production of free radicals and 
inflammatory responses, leading to the formation of a cavity in the center of the cord, 
surrounded by demyelinated axons [24]. The cavity will slow down the infiltration of 
macrophages, causing a blood-spine barrier, which further stops macrophage entry into the 
nerve tissues. In addition, astrocytes proliferate in the injured site, producing glial scars 
that further inhibits regeneration (Figure 1.2c). Together with the limited regenerative 
capabilities of adult neurons, the inhibitory environment formed on the injured site makes 





Figure 1.2 Anatomy overview of the spinal cord and pathophysiology process of SCI. (a) 
Schematic of the composition of spinal cord [23]. (b, c) The diagram shows the pathophysiology 
process after SCI [24] and the formation of glial scar [25].  
 
To enable the regeneration after SCI, a tissue-engineered strategy is highly needed to 
overcome the inhibitors and restore the hospitable microenvironment at the injury site:  
 (1) Cell implantation: Neural stem cells and Schwann cells are mainly used as the 
type of cells to be implanted into the injured site. To enhance the intrinsic regeneration, 
Tuszynski group has developed a cell therapy by combining neural progenitor cells 
together with neural stem cells, for treating SCI [26-28]. The derived neurons can actively 
grow and become insensitive to the inhibitor environment [29]. They have grafted the 
mixture of cells to serve as a relay circuit across the injured gap, up to 1 cm on the monkey 
model [30]. Schwann cells have been used for treating SCI due to its uniqueness in producing 
trophic growth factors, synthesizing ECM, and expressing cell adhesion molecules. Xu 




remyelination in the injured spinal cord, which is significant for functional recoveries [31-
32]. However, the growth direction for these cells still needs to be guided by extrinsic cues 
to pass through the injured gap more efficiently, such as a gradient of growth factors and 
channel scaffolds [33].  
 (2) Molecular therapy: Neurotropic growth factors have been widely used to 
promote neural development, survival, outgrowth, and branching. The commonly used 
growth factors include nerve growth factor (NGF), brain-derived neurotrophic factor 
(BDNF), and neurotrophin-3 (NT-3) [23, 34-36]. For each growth factor, NGF is vital to the 
development and regeneration of the nervous systems. BDNF supports motor neuron 
survival and promotes the axonal growth of motor and sensory neurons, which is similar 
to NT-3. To increase efficiency, these growth factors are commonly combined with cell 
implantation therapy for modulating neuronal regeneration.  
 (3) Bioengineered scaffolds: As it’s getting more and more clear that directional 
growth is significant in promoting functional reconnections after SCI. Multiple tissue-
engineered scaffolds have been designed to be implanted into the injured site for promoting 
regeneration. Poly(lactic-glycolic acid) (PLGA). developed by Langer group, have been 
applied to mimic the gray and white matter of spinal cord [37-38]. PLGA was further 
integrated with polyethylene glycol (PEG) to improve its biocompatibilities. These 
scaffolds have also been used together with cell therapy and growth factors as a directional 
guidance channel. Porous and compacted layered channel scaffold, made of agarose and 
alginate [39-40], have been studied as “bridges” to overcome the nonpermissive environment 




successful synapses formation with host neurons, restoration of an action potential by 
coupling growth factors (glial cell line-derived neurotrophic factor, GDNF), Schwann cells 
(SCs-GDNF) implantation and the guidance channel together (Figure 1.3) [41]. However, 
axons in these scaffolds are restricted to grow within the pores or between thin layers in 
the channels, which imposes spatial constraints, leading to low efficacy in neuron 
regeneration.  
 
Figure 1.3  Bioengineered scaffold coupled with growth factors and Schwann cells for 
partial recovery of function after SCI [41]. (a) Schematic drawing shows the experimental strategy 
and how the tissue was sampled. (b,c) Immunofluorescence staining images of hemisection SCI 
model without (b) and with (c) bioengineered scaffold. Green: biotinylated-dextran amine (BDA); 
Red: glial fibrillary acid protein (GFAP). (d) Extracellular recording of local field potential in the 
spinal cord. Representative traces (left) and related schematic drawings (right) (e) Quantitative data 






 Stem cells can renew themselves and differentiate into multilineage cells [42]. In 
recent years, stem cells have been widely investigated and used in clinical and biological 
applications. Here, we are focusing on human mesenchymal stem cells (hMSCs), towards 
bone application. hMSCs are derived from human bone marrow, with the capability to 
differentiate into mesodermal lineages, such as osteocytes, adipocytes, and chondrocytes, 
as well as ectodermal and endodermal lineages [43-44]. Recent advances in studying hMSCs 
successfully identified the mechanisms of osteogenic differentiation, which laid the 
foundation for using hMSCs for bone repair [45].  
How hMSCs different towards one lineage can be tuned by local or hormonal factors, 
specifically growth factors and some topographic surface structures. 
(1) Growth factors: The differentiation of mesenchymal cells mainly have three 
pathways that are controlled by different growth factors. Peroxisome proliferator-activated 
receptor γ (PPARγ2) is a positive transcription factor that promotes differentiation toward 
adipocyte while suppressing the osteoblast formation. While runt-related transcription 
factor 2 (Runx2) is a specific promoter for osteoblast gene expression in hMSC marrow 
stromal cells [46]. By modulating the growth factors, the osteogenesis process starts with 
osteoprogenitors, first differentiate into pre-osteocytes, and then mature osteoblasts 





Figure 1.4. In vitro differentiation pathway of mesenchymal cells [45]. 
 
Now, the most used method to differentiate hMSCs into osteoblasts is adding ascorbic 
acid, β-glycerophosphate, and dexamethasone into the growth medium to condition the 
differentiation [47-48]. Alkaline phosphatase (ALP) activities are used to monitor mineral 
aggregation initiated by the osteogenic induction of hMSCs, at the early stages of 
differentiation, confirming the pre-osteocytes stages. Alizarin Red and von Kossa staining 
are further used to evaluate the existence of mineralized modules during the final week of 
differentiation to identify the formation of osteoblasts [48].  
(2) Topological cues and external stimuli: Besides growth factors, the osteogenesis 
differentiation of hMSCs is sensitive to the growth condition, namely surface structures, 
curvatures, and some external stimulation. Topological cues, like trench and groove 
structures, showed positive differentiation outcomes [15]. Petersen et al. showed that convex 




traction force, resulting in a lift/push force on the interface, which promotes osteogenic 
differentiation of hMSCs [49]. In addition, cyclic mechanical stretching during the 
differentiation process can also dominate the osteogenesis of hMSCs. Young et al. reported 
that mechanical stretching increased the mRNA expression of core-binding factor α 1 
(Cbfa1) and ALP, which potentially promoted the osteoblastic differentiation of hMSCs 
[50]. Design and engineer these cues together into tissue scaffolds can be an effective way 
to modulate the differentiation process of stem cells.  
1.2.3 Stimulation 
Neurological disordered diseases, namely Parkinson's disease, Alzheimer's disease, 
epilepsy, and major depressive disorder [51-52], respectively, are becoming another 
emerging problem that needs to be solved. In the United States only, there is a number of 
2.4 million patients, and the government spent millions of dollars in the treatment and 
recovery process of the above-mentioned diseases [53]. Although, with the rapid 
development of neuroscience research in the past decades, there is an advance in our 
understanding of neuronal functions, the abilities to modulate and manipulate the dynamics 
of the nervous systems remain insufficient to treat these diseases.  
Through targeted stimulation of specific neural circuits, neuromodulation has been an 
invaluable approach for treating neurological diseases. External stimulation is used to 
modulate the behavior of injured or misfunctioned neuronal cells towards disease treatment 
and functional neuroscience studies. Neurostimulation is becoming one of the most 




Action potential (Figure 1.5) is the main mechanism of fundamental neural activities. 
At a resting state, the membrane potential is at approximately -70 mV of a single neuron, 
which is called resting potential. When there is an excitatory input from external stimuli or 
surrounding cells, the membrane potential will surpass the threshold (~ -55 mV), opens 
voltage-gated ion channels, causing an influx of positively charged sodium ions, which is 
called depolarization to “fire” the neurons. When the membrane potential increases to +30 
to 40 mV, the membrane repolarizes by the ion changes of the expulsion of potassium ions 
and gets back to the resting states. Any membrane potential changes lower than the 
threshold cannot generate the action potential, which is considered as failed imitations. The 
release of neurotransmitters also synchronizes with an action potential, which is a process 
of information transfer from electrical signals to chemical signals.  
 





Multiple external systems have been applied to modulate the action potential process 
in order to stimulate or inhibit neurons.  
(1) Electrical modulation: Electrodes are the most widely used technology for 
stimulating neurons, as well as recording neuronal activities. Starting from 1957, sharpened 
tungsten electrodes with sub-micrometer diameter tip size was firstly used to record 
neurons and axons activities in the mammalian brain, as a first demonstration of 
extracellular action potentials from cat brain [54]. Following with these technologies, newer 
probes have been developed, ranging from tetrodes to microfabricated silicon Michigan-
type microelectrode arrays (MEAs) [55-56]. Together with the development of 
semiconducting industries, current Utah MEAs chips can integrate signals from multiple 
channels, up to 1024 channels [57-58]. The chips can process extract signals in different 
frequency bands, enabling the detection of at least two different types of voltage signals, 
local field potential (LFP), which reflect collective transmembrane currents from multiple 
neurons, and action potential from signal neurons with the capabilities to record signal 
spikes within a few milliseconds [59]. The frequencies of the signals are typically < 100 Hz 
for LFPs and > 250 Hz for single-neuron action potentials. Stimulation signals can also be 
conducted through these recording electrodes to modulate neuronal activities.  
Although MEAs chips have been widely used for in vitro neural activity studies, the in 
vivo and therapeutic application of electrode-based stimulation is still highly limited in its 
invasiveness and biocompatibility. Recently, to improve biocompatibilities, hydrogels, and 
polymer systems have been utilized to make soft electrodes. For example, a poly(vinyl 




(PEDOT) and other copolymers of collagen and/or the organic semiconductor polypyrrole, 
used as an improvement to traditional silicon-based electrodes [60-61]. Also, PEDOT mixed 
with poly(styrene sulfonate) (PEDOT: PSS) coating on standard metallic electrodes are 
also used to increase the signal to noise ratio (SNR) when interacting with neuronal units 
[62]. Graphene and carbon nanotubes were also used as another candidate here, due to its 
high conductivities and good biocompatibilities [63]. To reduce the invasiveness during 
implantation, there is another trend to make the electrodes in a three-dimensional (3D) 
format. Lieber’s group has shown the feasibility of applying mesh electronics of brain 
recording and stimulating electrodes, which makes the 3D electrodes injectable and further 
increases the contact area of the electrodes to the brain [64-69] (Figure 1.6). However, one 
of the fundamental challenges of using electrodes is due to the large potential drop at the 
electrode/tissue interface, which can also lead to electrolysis of water, electrode 
degradation, and tissue damage [70]. Lack of cellular specificity is another limitation of 






Figure 1.6 Syringe-injectable electronics for brain activities, recording, and stimulating 
[68]. (a-c) Schematics of injectable electronics. (d) Schematic shows the injection process of mesh 
electronics into a mouse brain. (e) Optical image of the injection process. (f,g) Schematics of two 
targeted brain functional location: cerebral cortex (f) and lateral ventricle. (h) Images of the mesh 
electronics five weeks post-injection. (i) Overlaid bright field and epifluorescence images from the 
region indicated by the white dashed box in h. (j) 3D reconstructed confocal image from the region 




electronics injected into a mouse brain. (l), Superimposed single-unit neural recordings from one 
channel after 300–6,000 Hz band-pass filtering. 
 
(2) Light modulation: With the development of optogenetics, light is used to modulate 
neuronal activities experimentally and clinically. Optogenetics can perturb and probe the 
neural activities on genetically modified neurons [71]. This method relies on the genetic 
introduction of light-sensitive microbial ion channels and pumps, called opsins, into 
mammalian neurons, and other electrically active cells [72-73]. Opsins are transmembrane 
proteins harboring the chromophore retinal, which changes conformation in response to 
blue light, and this drives ion transportation. These proteins can be used for both excitation 
and inhibition of neural activities. Excitatory opsins, in which channelrhodopsin 2 (ChR2) 
is the most common one, are cation channels that mediate membrane depolarization to 
initiate action potentials in response to the visible light. Inhibitory opsins are proton or 
chloride pumps, namely halorhodopsin and archaerhodopsin, which transport ions against 
their concentration gradients to slice neurons through optical driven hyperpolarization [74]. 






Figure 1.7 Schematic showing the mechanism of optogenetics (Image source: Biorender). 
 
However, the limitation of light neuromodulation is coming from the penetration depth 
of light. For optogenetics, although, after the development of ChR2, several opsins with 
varied absorption spectra have been discovered and engineered, it is still limited in the 
visible range [75-76]. Because the visible light can be scattered and absorbed by neural tissue, 
which has very low tissue penetration depth, optogenetics neuromodulation still relies on 
implanted devices to deliver light for stimulation. More significantly, the requirements for 





(3) Magnetic modulation: Magnetic field is used for neurostimulation due to its 
profound tissue penetration depth and non-invasiveness. Transcranial magnetic stimulation 
(TMS) has been used as a non-invasive stimulation method for the understanding of neural 
activities and for therapy application [77]. In TMS, a fast pulse of magnetic files is generated 
perpendicular to the coil plane, which will induce an electric current at the surface of the 
targeted brain for neural activation. TMS has been approved to be effective for the 
treatment of Parkinson’s disease, epilepsy, stroke, and chronic pain [78-80]. However, since 
magnetic files cannot be focused, all the neurons on the brain surface within the applied 
magnetic field will be stimulated, showing no spatial confinement. To increase the spatial 
resolution, micromagnetic stimulation (µMS), using micrometer-scale coils, has been 
developed [81]. However, the achieved spatial resolution is still on the centimeter scale, in 
which single-neuron resolution still cannot be achieved. Also, neuron type-specific 
stimulation cannot be achieved by using magnetic stimulation.  
(4) Ultrasound modulation: Compared with the magnetic field, ultrasound 
neurostimulation has attracted people’s attention because of its high spatial resolution and 
deep penetration depth [82-83]. Although high-frequency ultrasound showed higher spatial 
resolution, low-frequency ultrasound (< 2MHz) is widely used in brain stimulation due to 
its deeper tissue penetration depth.  
Transcranial focused ultrasound has been demonstrated to evoke a motor response in 
mice [83-84], rabbits [85], and sensory/motor responses in humans [86-87]. However, two recent 
papers argued that these responses could be a consequence of indirect auditory stimulation 




neurons in cultured brain slices [90] and isolated retina[91-92], where no auditory circuitry is 
involved. One big challenge in ultrasound neural modulation, which partly accounts for the 
mentioned controversy, is that delivery of transcranial ultrasound would inevitably go 
through the skull, and eventually reach the cochlear through bone transduction. Moreover, 
the presence of the skull will reflect the acoustic wave and compromise ultrasound focus, 
resulting in poor spatial resolution. 
 
1.3 Advances in nanostructures for cell modulation 
Nanostructures, with its fine features to mimic the hierarchy structures of ECM, 
showed the potential in modulating cellular behaviors. Cells can sense the presence of 
nanostructures and accommodate morphologies according to the patterns of 
nanostructures. Such morphological changes were studied to show the potential in cellular 
modulation processes.  
1.3.1 Nano-bio interfaces for promoting neuronal regeneration 
Surface topography at the nanoscale has been reported to promote neuron outgrowth in 
vitro. Nanogrooves with a width of less than 400nm have shown to alter the growth 
morphologies of cell-cultured on top [93]. A clear elongation and stretch along the direction 
of the nanogrooves have been noticed on neuron and neuron-like cell lines, for example, 
embryonic cortical neurons, DRG (dorsal root ganglia) and PC12 cells [94]. Nanopillars, 
with a diameter in 75-400 nm and height in 700 nm to 2 µm, have been reported to show a 




close contact with the nanopillars [95-96]. Aligned electrospinning fibers in the diameter of 
400-600 nm have been shown to orient DRG alignment and SC migration in vitro [97-98]. In 
vivo, demonstrations have been made in the PNS systems to promote neuronal regeneration 
[99]. Closely packed vertical nanowires have also been proved to facilitate the axonal growth 
of cultured neurons [100]. Other conductive nanostructures have also been used. Carbon 
nanotubes (CNT) mesh films were cultured with spinal cord tissue slices, showing 
promoted growth and functional reconnections [101].  
However, the detailed mechanism remains unknown. Several hypotheses have been 
made: (1) The topographic cues change the way how proteins on the cytoskeleton interact 
with the surface and organize the distribution of these adhesion proteins to determine how 
neurons bind to the surface. Pieces of evidence have been proved that upregulated release 
of actin-based cytoplasmic projections, lamellipodia, and filopodia, on the nano-
topographical environment [102-103]. (2) Topographical cues may have an impact on the 
differential localization of receptors and their downstream signaling pathways, resulting in 
the formation of highly polarized cellular morphology and different functional behaviors 
of the neurons. (3) Topographical structures may induce nuclear distortion, which promotes 
the expression rate of differential gene and promote neuronal growth [104]. Although there 
is no clear evidence showing which mechanism is the dominating factor, the effect of 
nanostructure in promoting neuronal growth is a true fact. It is also highly possible the 




1.3.2 Nanostructures serve as cues for stem cell differentiation 
Nanotechnologies have been used to mimic the nanoscale feature of ECM (Figure 1.7). 
Compared to flat substrates, nanoscale featured substrates have been reported to enhance 
the adhesion, growth, and osteogenic differentiation of hMSCs [6]. Close packed silica 
nanoparticles modified flat substrates showed promoted hMSCs differentiation, which is 
independent of the substrate materials [105]. Increased density of F-actin fibers has been 
noticed, which indicates nanoparticles can enhance cell attachment, which in turn may 
inhibit cell migration, therefore favoring cell differentiation functions. The differentiation 
of hMSCs is sensitive to the dimensions of the surface patterns. Three types of attachment 
of hMSCs have been proved on the groove patterns [106]. When the width is larger than 5 
µm, osteoblast differentiation is preferred. Superficially adhered and round cells are 
formed. For the grooves with a width less than 5 µm, spread attachment with increased cell 
density and better orientation control was achieved on the cultured hMSCs. When further 
decreasing the size of the groove patterned to nanofeatures, better osteogenic 
differentiation with enhanced osteocalcin deposition was obtained. Positive effect on 
regulating hMSCs differentiation has been proved on nanogratings, with 250 nm line width 
made of polydimethylsiloxane (PDMS) [16]. Interestingly enough, disordered nanodots 
stimulated hMSCs to produce bone mineral in vitro, even with absence of osteogenic 
supplements at levels similar to stem cells grown on flat surface with exposure to 
osteogenic media [17, 107].  
Similar to neurons, the differentiation of hMSCs is highly possible to be modulated by 




triggers the formation of osteogenic and myogenic differentiation markers [108]. hMSCs can 
sense and transduce nano-topographical signals through focal adhesions and actomyosin 
cytoskeleton contractility to induce differential gene expression.  
1.3.3 Nanostructures to stimulate neuronal activities 
Nanostructures have shown great promise for neural stimulation via the photothermal 
effect, photoelectric effect, magnetic field excitation, and ultrasound excitation. Gold 
nanoparticles and nanorods are most studied for photothermal neural stimulation[109-110]. 
The Pu group demonstrated binding of bioconjugated nanostructures to transient receptor 
potential cation channel subfamily V member 1 (TRPV1) [111], a thermal sensitive channel 
on the neuron membrane. To activate these channels, the local temperature needs to 
increase up to 43 ˚C to reach the threshold of the thermal-sensitive ion channels [111-112]. 
Such a large temperature rise imposes a fundamental challenge for neuronal stimulation 
under physiological conditions. The Tian and Bezanilla groups reported photoelectrical 
stimulations on cultured neuronal cells with silicon-based nanostructures [113]. The 
absorption of these Si nanostructures is within the visible range from 520 to 800 nm, with 
limited penetration into the scattering brain tissue. The magnetic field has been widely used 
for non-invasive neural modulation because of its high penetration depth. The Anikeeva 
group recently utilized the magneto-thermal effect of the paramagnetic nanoparticles to 
activate the thermal sensitive ion channels [114]. The Khizroev group applied the magneto-
electric properties of the nanoparticles to perturb the voltage-sensitive ion channels to 
modulate neurons [115]. Restricted by confinement of the magnetic field applied, it is 




been used as a carrier for the ultrasound to disrupt the blood-brain barrier (BBB) and to 
stimulate neurons in adult mice [116]. With the help of transcranial focused ultrasound, a 
spatial resolution of 1.55 mm longitudinally at 1 MHz ultrasound is achieved. The 
ultrasound excitation is not meeting the single-neuron resolution, and the physiological 
stabilities of the microbubbles raise concern for further in vivo applications [117]. 
1.3.4 Limitations of current strategies 
Although nanostructures showed promising capabilities in modulating cellular 
activities, there are still some limitations and gaps that cannot be achieved by using current 
nanostructures.  
(1) Due to the uniqueness of nanostructures, promoted directional guidance along long-
distance (> 1mm) can hardly be achieved. Typically, for SCI, the lesion site is usually in 
the size of a few millimeters.  
(2) Current nanostructures are still fabricated mainly on 2D subtracts, which can not fit 
into the 3D nature of tissue for in vivo systems and translational applications.  
(3) For neurostimulation, current nanostructure mediated stimulation still has high 
invasiveness and low spatial-temporal resolution. A new method is needed to achieve 
transfection free stimulation with deep tissue penetration depth, which could be potentially 





1.4 Outline & Organization 
 Regarding the advances of nanostructure used in interfacing with cellular systems 
and the limitations of current strategies, in this dissertation, we developed a scaffold named 
“Nanoladder” to interfacing with neurons for promoting directional neural regeneration 
and contacting with hMSCs to facilitate the differentiation towards bone lineage. We also 
designed a photoacoustic nanotransducers to modulate neuronal activities. The outline is 
listed, as below:  
 Chapter 1 discusses the motivation of cell modulation and points out that 
nanostructures have potential in modulating cellular behaviors at the aspects of 
regeneration, differentiation, and stimulation.  
 Chapter 2 focuses on neuronal regeneration in vitro and ex vivo. A two-
dimensional (2D) nanoladder scaffold will be designed to mimic the hierarchy structure of 
the spinal cord and fabricated on the cover glass. The nanoladder scaffold is proved to 
promote the directional growth of embryonic neurons in vitro. A morphological and 
functional connection is further achieved on the nanoladder by using organotypic spinal 
cord tissue slices as the ex vivo model.  
 Chapter 3 talks about how to convert a 2D nanoladder scaffold into a 3D format 
in modulating cellular behavior in a heterogeneous cell culture system. A high 
biocompatible material, Silk, will be coupled into the nanoladder to make a new generation 
of silk roll for tissue engineering. How the 3D silk rolls interact with neurons, and hMSCs 




and hMSCs will be demonstrated to show the potential of achieving innervated bone 
regeneration.  
 Chapter 4 states the potential of using photoacoustic nanotransducers (PAN) to 
induce optoacoustic neurostimulation. We will apply surface modification on the PAN and 
enable sufficient binding to neuronal cells. The surface of the PAN will also be 
functionalized with antibodies to achieve specific binding. The neurostimulation process 
will be evaluated, and a possible mechanism will be studied.  





CHAPTER 2: 2D nanoladder for facilitating directional neurite growth 
This work represented in this chapter was published on ACS Biomaterials Science & 
Engineering [118]. Copyright by The American Chemical Society. 
Spinal cord injury (SCI) in the central nervous systems (CNS) is one of the most severe 
diseases affecting human life [119-120]. Acute SCI is known to have a high death and disability 
rate. As reported by the National Institute of Health (NIH) [121], there is an estimated 
number of 291,000 people in the U.S. having SCI, ranging from 249,000 to 363,000 
persons, with an approximately 17,730 new cases each year [122]. 55% of all people who 
suffer SCI are between the ages of 16 and 30 at the time of injuries. The average yearly 
expenses, including health care costs and living expenses, cost a financial burden of $4 
billion to the U.S. government. Unfortunately, although surgical and/or pharmacological 
interventions are practiced clinically [123], only limited functional recovery has been 
reported. Due to the limited abilities of spontaneous neuronal regeneration following SCI, 
up to now, there are no efficient treatment methods clinically and pre-clinically towards 
SCI [38, 124]. No efficient solution has been developed to restore the ECM structure in the 
spinal cord for successful functional recoveries.  
After injuries, axonal regeneration over a long distance is challenging due to a lack of 
orientation guidance. Biocompatible scaffolds have been used to mimic the native 
organization of axons to guide and facilitate axonal regeneration. Those scaffolds are of 
great importance in achieving functional connections of the nervous system. We have 




of axons. The nanoladders, composed of micron-scale stripes and nanoscale protrusions, 
were fabricated on the glass substrate using photolithography and reactive ion etching 
methods. Embryonic neurons cultured on the nanoladder scaffold showed significant 
neurite elongation and axonal alignment in parallel with the nanoladder direction. 
Furthermore, the nanoladders promoted axonal regeneration and functional connection 
between organotypic spinal cord slices over 1 mm apart. Multimodality imaging studies 
revealed that such neuronal regeneration was supported by a directional outgrowth of glial 
cells along nanoladders in the organotypic spinal cord slice culture as well as in the 
coculture of glial cells and neurons. These results collectively herald the potential of our 
nanoladder scaffold in facilitating and guiding neuronal development and functional 
restoration.  
2.1 Introduction 
Neurons are naturally encompassed by a network in a highly aligned manner.[125] 
During neuronal development, directional outgrowth is of great importance in guiding 
neurites to the targets, such as postsynaptic neurons, for effective communication.[38, 124] 
Limited neuronal regeneration following central nervous system damage poses significant 
challenges for the treatment of injuries.[119-120] Nanostructures, partially mimicking the 
structure of the extracellular matrix, have shown potential in facilitating neurite outgrowth 
as well as regeneration. Uniaxially aligned nanofiber arrays with a fiber diameter of 250 
nm and length in the range from 500 µm to 1 mm were applied to direct and enhance axonal 
extension during regeneration.[126] Nanogroove structures with feature size ranged from 50 




of the neuronal cells cultured on the surface [93] Arrays of nanopillars with diameters of 
approximately 150 nm and heights of several µm in close contact with neurons significantly 
reduced cell mobility and pinned the neuronal cells to the pillars to grow.[127] Nanowires 
with diameters of 72 ± 8 nm, lengths of 7 to 10 µm, and density of 17.9 nanowires/µm2 
were found to promote the growth of single and elongated major neurites via axon-first 
neurogenesis.[100] All of these studies only focused on understanding the neurite outgrowth 
at the cellular level, where no functional performances were measured or evaluated. Very 
recently, carbon nanotubes were demonstrated to increase neuronal electrical signaling.[128] 
Meshes of randomly distributed carbon nanotubes promoted physiological reconnections 
between segregated spinal cord slices placed at a distance between 300 to 800 µm.[129] 
Notably, the meshed carbon nanotube scaffolds lack controlled alignment of 
nanostructures to facilitate directional neurite regeneration. Therefore, it remains 
challenging to achieve regeneration and reconnection over longer distances, such as above 
1 millimeter, a critical gap that injured lesion sites typically have in the clinical cases.[37] 
Here, we report a nanoladder scaffold that is able to guide millimeter-scale neural 
growth along with predefined directions and to promote neurite elongation through 
nanostructures with a subcellular dimension. Distinct from other nanostructures mentioned 
above, the nanoladder is composed of micrometer-wide stripes and nanometer-scale 
protrusions on each stripe (Figure 2.1). The nanoladder structure is unique in that it highly 
mimics the native structure of the axonal bundles in spinal cord white matter. The 
micrometer-wide stripes provide directional guidance to the growing neurons and glial 




trigger neurite outgrowth and regeneration. We use SiO2 based cover glasses as the 
substrate to fabricate nanoladder structures, via robust photolithography and reactive ion 
etching (RIE) methods.[130-131] This substrate provides high biocompatibility for neural 
adhesion and transparency for optical imaging to explore the growth mechanism. To 
evaluate the concept of nanoladder-mediated growth and regeneration, we first cultured 
primary embryonic neurons on the nanoladders to verify that nanoladders can guide 
directional outgrowth of axons. Then, using organotypic spinal cord slices placed 1 to 1.5 
millimeter apart as an ex vivo injury model [132], we showed that nanoladders promote 
axonal regeneration and functional connection after injuries. Furthermore, we explored the 
outgrowth mechanism using various imaging modalities, including immunofluorescence, 
scanning electron microscopy (SEM), and stimulated Raman scattering (SRS) microscopy.  
 
Figure 2.1. Schematic of a nanoladder scaffold (blue) mimicking the multiscale 





2.2 Methods  
2.2.1 Materials 
The photoresist AZ9260 and AZ400K developer were purchased from AZ Electronic 
Materials, NJ. Polystyrene beads with a diameter of 500 nm, Poly-D-Lysine, 
Penicillin/Streptomycin, Bovine Serum Albumin (BSA), Triton x-100, OsO4, strychnine, 
and bicuculline were purchased from Sigma-Aldrich Chemical Co, MO. Glutamine-
Dulbecco's Modified Eagle Medium (DMEM), Neurobasal medium, B27, N2, glutamine, 
anti-MAP2, anti-Tau, anti-chicken secondary antibody, and goat anti-mouse antibody were 
purchased from Thermo Fisher Scientific Inc, MA. Trypsin/Ethylenediaminetetraacetic 
acid (EDTA) and Phosphate-buffered saline (PBS) were purchased from VWR, PA. Fetal 
bovine serum (FBS) and horse serum (HS) were purchased from Atlanta Biologicals, GA. 
All other chemicals were purchased from Sigma-Aldrich or Dot Scientific and used without 
further purification. 
2.2.2 Fabrication and characterization of nanoladder scaffolds 
All fabrications were carried out in the cleanroom in Birck Nanotechnology Center at 
Purdue University (West Lafayette, IN, United States). Cover glasses (22 mm × 22 mm, 
VWR, PA) were used as the substrates in nanoladder fabrication. The cover glasses were 
cleaned through multiple steps of solvent rinse in the sequence of toluene, acetone, 
isopropanol, and deionized water before the photolithography process. During the 
photolithography, photoresist AZ9260 (AZ Electronic Materials, NJ) was spin-coated onto 




After soft-baked at 110 ℃ for 180 seconds, the cover glass substrates were exposed to UV 
light by using a mask aligner (MA6, Suss) with an expose the power of 14.0 mW for 81 
seconds. The developing process was carried out by applying AZ400K developer (AZ 
Electronic Materials, NJ) diluted with deionized water to a ratio of 1:3. Then, the micron-
stripes were fabricated onto the cover glasses substrates via RIE (STS-AOE DRIE). During 
the etching process, a pressure of 4 mTorr and the constant CF4 gas flow at 14 cm were 
used. The radio-frequency (RF) power was set at 400 W, and bias power was 50 W for the 
entire etching process. The substrates were etched for 25 minutes to reach the etching depth 
of 10 µm. The substrates were sonicated in acetone solvent for 10 minutes to remove the 
PR residues. Afterward, the nanoprotrusions were fabricated onto the micron-stripes. 
Polystyrene beads with a diameter of 500 nm (Sigma-Aldrich, MO) were deposited to the 
prepared micron-stripe substrates with a spin coating speed of 2000 rpm/s for 45 seconds 
and used as the etching mask. The same etching process was utilized for the 
nanoprotrusions with a decrease etching time for 3 minutes. Nanoladder scaffolds were 
obtained after the acetone rinse to remove the unreacted polystyrene beads. 
2.2.3 Animals 
Embryonic day (E) 14–15 rats, obtained from female, pregnant Sprague–Dawley rats 
bred were used. All animal care was carried out in accordance with the National Institute 
of Health Guide for the Care, and Use of Laboratory Animals (NIH Publications No. 80-
23; revised 1996) and was operated under protocol 1406001097 approved by Purdue 
University Animal Care and Use Committee, and protocol 000197 approved by Boston 




2.2.4 Spinal cord primary neuron culture and neuron-glial co-culture 
All substrates used in the embryonic neuron cell cultures were immersed in 0.01% 
Poly- D-Lysine (Sigma Aldrich, MO) overnight at 4°C and washed in PBS before culture 
initiation. Primary spinal cord neurons were obtained from Sprague-Dawley rat E15 
embryos. The spinal cords were isolated and placed in the L15 medium. Meninges were 
removed, and spinal cords were cut into small pieces, dissociated by incubation in 0.05% 
trypsin/Ethylenediaminetetraacetic acid (EDTA, VWR, PA) 15 minutes at 37°C and 
triturated every 5 minutes. Dissociated cells were washed with and triturated in 10% heat-
inactivated fetal bovine serum (FBS, Atlanta Biologicals, GA), 5% heat-inactivated horse 
serum (HS, Atlanta Biologicals, GA), 2 mM Glutamine-Dulbecco's Modified Eagle 
Medium (DMEM, Thermo Fisher Scientific Inc, MA) and cultured in 10 cm plates for 30 
min at 37 °C to eliminate glial cells and fibroblasts. The supernatant containing neurons 
was collected and seeded on poly-D-lysine coated cover glass and incubated in a 
humidified atmosphere containing 5% CO2 at 37°C with 10 % FBS + 5 % HS + 2 mM 
glutamine DMEM. After 16 hours, the medium was replaced with Neurobasal medium 
(Thermo Fisher Scientific Inc, MA) with 2% B27 (Thermo Fisher Scientific Inc, MA), 1 
% N2 (Thermo Fisher Scientific Inc, MA) and 2 mM glutamine (Thermo Fisher Scientific 
Inc, MA).  
For neuron-glial coculture, glial cells were obtained from P2-4 rat pup cortices. Glial 
cells were seeded onto the substrates without coating and were cultured with DMEM + 
10% FBS + 1% Penicillin/Streptomycin (Sigma-Aldrich, MO) for one week before the E14 





2.2.5 Immunofluorescence staining 
To track neurite outgrowth, cells were fixed with 4% paraformaldehyde for 20 minutes. 
After 3 washes, cells were blocked in 5% Bovine Serum Albumin (Sigma-Aldrich, MO) 
for 30 minutes and permeabilized with 0.2% triton x-100 (Sigma-Aldrich, MO). Then cells 
were incubated with chicken monoclonal anti-MAP2 (1:1000) and mouse monoclonal anti-
Tau (1:1000) antibody for 2 hours, and then with goat anti-chicken secondary antibody 
(1:1000, Thermo Fisher Scientific Inc, MA) or goat anti-mouse antibody (1:1000, Thermo 
Fisher Scientific Inc, MA) for 1 hour at room temperature.  
2.2.6 Scanning electron microscopy 
Cells were fixed in glutaraldehyde solution and then rinsed three times in Phosphate-
buffered saline (PBS, VWR, PA). Subsequently, samples were immersed in OsO4 (Sigma-
Aldrich, MO) for 40 minutes and then rinsed 3 times in PBS, followed by dehydration. The 
dried samples were mounted on aluminum stubs and coated with platinum for imaging.  
2.2.7 Organotypic spinal cord slice culture 
Spinal cords or cortex from Rat E15 embryos were isolated and sliced into slices in the 
thickness of 250 µm with a tissue slicer. Slices were then placed on nanoladders or cover 
glasses. Organotypic slices were cultured with 1 mL of medium containing 67% DMEM, 
8% sterile water, 25% fetal bovine serum, and 25 ng/mL nerve growth factor; adjusted to 




37 °C for 7 to 14 days before fixation, staining, and imaging. 
2.2.8 Stimulated Raman Scattering (SRS) microscopy 
SRS images were obtained as previously described.[133] For each SRS image, the Z 
position of the focus was adjusted near the equatorial plane of the neurons so that the soma 
and neurites were both clearly visualized. The pump (799 nm) and Stokes (1040 nm) 
powers before the microscope were maintained at 20 and 100 mW, respectively. Both the 
pump and Stokes beams were linearly polarized. No cell or tissue damage was observed. 
Images were acquired at 2 µs pixel dwell time.  
2.2.9 Electrophysiology 
Electrophysiological recordings were conducted at room temperature in normal Krebs 
solution containing (mM): NaCl, 156; KCl, 4; MgCl2, 1; CaCl2, 2; Hepes, 10; glucose, 10 
(Dot Scientific, MI). Disinhibited rhythmic bursts were obtained by bath co-application of 
strychnine and bicuculline (1 µM and 20 µM, respectively, Sigma-Aldrich, MO). The pH 
was adjusted to 7.4 using NaOH. Glass pipettes used for recording local field potentials 
were pulled from filamented borosilicate glass capillaries (BF150-86-10, Sutter 
Instruments) using a micropipette puller (Sutter Instruments, P-97), 0.8 to 1.5 MΩ 
resistance, and filled with normal Krebs solution. Electrical signals were amplified with a 
MultiClamp 700B amplifier (Molecular Devices) and digitized by Digidata 1550 
(Molecular Devices). Electrical stimulation was performed using a stimulus isolator 
(World Precision Instruments) and applied through a bipolar stimulating electrode (FHC). 




analyzed through NEO 0.3.3 (Github), a package for representing electrophysiology data 
in Python. A low pass filter (cut-off frequency = 0.2 Hz) was applied to denoise the 
recording signals[134]. 
2.3 Nanoladder design and fabrication 
During neuronal development or regeneration after injury, axons outgrow to reach their 
targets and form functional connections.[120, 135] We first investigated the efficacy of using 
nanoprotrusions as mechanical cues to facilitate neurite outgrowth. Nanoprotrusions of 
diameters of 250 and 500 nm and heights in the range of 1.0 to 2.5 µm were fabricated on 
silicon wafers via RIE methods. SiO2 nanoparticles with the diameters of 250 and 500 nm 
(Sigma Aldrich, MO) were used as etching masks. Silicon wafers were chosen here because 
it is the most commonly used substrate in nanostructure fabrication. As reported before [136], 
diameters of the resulted nanoprotrusions were determined by the size of SiO2 
nanoparticles, and the height was controlled by the RIE etching time. The density of 
nanoprotrusions on the surface was varied by changing the concentration of SiO2 
nanoparticle solution. Embryonic neurons were cultured on the poly-D-lysine (Sigma 
Aldrich, MO) pre-coated surface of the nanoprotrusions for 7 days. Among the various 
dimensions we tested, more elongated neurites were found on the nanoprotrusions with 
500 nm in diameter and 2 µm in height (Figure 2.2 a, b). Therefore, nanoprotrusions of 
such dimensions were used through the rest of our study.  
To examine nanoscale details of neurite growth, we fixed the neurons for SEM 




density changed. Specifically, when the concentration of SiO2 nanoparticle solution used 
was 0.5 mg/mL, and the resulted density of nanoprotrusion was (0.17 ± 0.06) ×108 cm-2, 
outgrowing neurites tended to grow in the spaces between the nanoprotrusions and wrap 
around the protrusions as anchoring positions for further expansion (Figure 2.2c). As the 
concentration of the SiO2 nanoparticle solution increased to 1.0 mg/mL, which resulted in 
a higher estimated density of (0.80 ± 0.14) × 108 cm-2 (Figure 2.2d), a single neurite with 
elongated length was observed. Interestingly, consistent with the previous report, neurites 
are prone to attach to the tip of the nanoprotrusions to grab and climb following the course 
of the nanoprotrusions.[100] These findings suggest that the nanoprotrusions offer 
mechanical cues to the neurite outgrowth, with nanoprotrusion dimension and density 






Figure 2.2. SEM images of the nanoprotrusion fabricated on a silicon wafer and cultured 
with embryonic neurons for 7 days. (a) Nanoprotrusions with diameter of 250 nm and height of 
~1 µm; (b) Nanoprotrusions with diameter of 500 nm and height 0f ~2 µm; (c) Low density of 
(0.17 ± 0.06) ×108 cm-2; (d) High density of (0.80 ± 0.14) × 108 cm-2. 
 
Nanoladder scaffolds were fabricated on the SiO2 based cover glass via 
photolithography and two-steps of RIE, as illustrated in Figure 2.3a. The cover glass is 
chosen here because of its low price, high biocompatibility, and excellent transparency for 
the convenience of optical imaging. A layer of photoresist (PR) AZ9260 (AZ Electronic 
Materials, NJ) with a thickness of approximately 10 µm was first spin-coated onto the cover 
glass, followed by a photolithography process to obtain the micrometer-wide stripe patterns 




providing an etching rate of 290 nm/min for the glass and 194.4 nm/min for PR, which 
corresponded to the selectivity of 1:1.49 (PR/glass). The stripe pattern with a width of 20 
µm and a spacing of 20 µm between each stripe was therefore successfully fabricated onto 
the cover glass (Figure 2.3b).  
 
Figure 2.3. Fabrication of nanoladder. (a) Scheme of the nanoladder fabrication process. 
(b,c) Top viewed SEM images of micronstripes (b) and nanoladders scaffold (c). 
 
Patterns with other dimensions, including 20 µm width and 50 µm spacing, 20 µm 




designed and fabricated based on the same photolithography process (Figure 2.4 a-d). 
Among all tested stripes, only the ones with 20 µm width and 20 µm spacing showed 
directional growth of neurites after culturing with embryonic spinal cord neurons. We 
attributed this intriguing selectivity to the fact that 20 µm is the most comparable size with 
the neuronal soma, which allows neurons to stay on the top and/or side of the stripes to 







Figure 2.4. Pattern design of the nanoladder scaffolds. (a-d) Transmission optical images 




interspacing between each group is 100 µm; (b) Stripes with 20 µm width and 20 µm spacing; (c) 
Stripes with 20 µm width and 50 µm spacing; (d) Stripes with 20 µm width and 100 µm spacing, 
respectively. (e-h) SEM images of the as-designed nanoladder scaffolds cultured with embryonic 
neurons for 10 days. 
 
Afterward, the nanoprotrusions on the microstripes were obtained by a second step of 
the RIE process, using polystyrene beads (Sigma-Aldrich, MO) with a diameter of 500 nm 
as the mask (Figure 2.3c). As indicated in the cross-section SEM images in Figure 2.5, 
the height of the stripes of the nanoladder scaffold is 5.40 ± 0.28 µm (Figure 2.5a), and 
the height of the nanoprotrusions is 2.08 ± 0.23 µm (Figure 2.5b). 
 
Figure 2.5. Cross-section SEM images of the nanoladder scaffold. (a) Cross-section SEM 





2.4 Nanoladder interfacing with neurons in vitro 
 To evaluate the interaction between neurons and the nanoladder scaffolds, we 
harvested embryonic spinal cord neurons from E14- E15 Sprague-Dawley rat (Charles 
River, MA) embryos and seeded them onto the nanoladder scaffolds. After 7 days in culture, 
cell growth was assessed by optical imaging and electron microscopy (Figure 2.6). We 
compared three different substrates as scaffolds for neuronal cultures, including cover glass 
as a control (Figure 2.6 a, d), cover glass with only nanoprotrusions (Figure 2.6 b, e), and 
nanoladders (Figure 2.6 c, f). To visualize the dendrite outgrowth, we stained the cells 
with anti-MAP2 (Abcam, MA) for dendrites (Figure 2.6 a-c). Neurons cultured on the 
nanoprotrusions showed a significant dendrite elongation (Figure 2.6 b), compared with 
those in the control group (Figure 2.6 a). Significantly, in the nanoladder group, a 
directional neurite elongation along the orientation of the nanoladders was observed 
(Figure 2.6 c). We further used SEM to visualize more detailed neurite structures. In the 
control group (Figure 2.6 d), the neurites tended to aggregate into bundles, while neurons 
in the nanoprotrusion group showed a more spread out and expanded growth pattern 
(Figure 2.6 e). In the nanoladder group, neurites were noticeably guided by the nanoladder 
and followed the orientation of nanoladders (Figure 2.6 f).  
Quantitative analysis of the neurite elongation and orientation was performed based on 
the immunofluorescence images. The neurite elongation was determined by measuring the 
average neurite length in the ImageJ via NeurphologyJ plugins. As displayed in Figure 2.6 
g, the average total neurite lengths per neuron are 259.91 ± 19.94 µm (n=31), 358.46 ± 




nanoladder groups, respectively. The neurite lengths observed from nanoprotrusions and 
nanoladder groups are significantly longer than that of the control group, p = 0.0053 for 
the nanoprotrusion versus cover glass group and p = 2.37 × 10-4 for the nanoladder versus 
cover glass group, respectively. These results indicate that nanoprotrusions effectively 
promote neurite outgrowth.  
The orientation of the neurites was determined by measuring the angle between the 
primary neurites and nanoladder orientations. (Figure 2.6 h, i).  In the control group, 
embryonic neuron cells displayed a uniform distribution over a broad range of orientation 
angles in the degree of  -180˚ to 180˚, with 27.5% of the neurite orientation within the 
angle of -30˚ to 30˚ (n = 91). On the contrary, the majority of the neuron cells on the 
nanoladder group were aligned in parallel to the orientation of the nanoladders, with 
79.12% of the neurite orientation within the -30˚ to 30˚ range (n = 80). This comparison 
demonstrates that nanoladders predefine a specific direction and effectively facilitate the 





Figure 2.6. Nanoladders enable directional outgrowth of cultured embryonic neurons. (a-
c) Immunofluorescence staining images of embryonic neuron cells cultured on the surface of 
different scaffolds. MAP2 stained embryonic neuron cells cultured on the cover glass (a), on 
nanoprotrusions (b), and on nanoladder scaffolds (c). The arrow indicates the direction of the 
nanoladder scaffold. (d-f) SEM images of neuron cells cultured on the cover glass (d), on 
nanoprotrusion (e), and on nanoladder scaffolds (f). (g) Average neurite lengths measured from the 
immunofluorescence staining images. (h,i) Histograms of neurite angles measured from the cover 
glass sample (h) and nanoladder scaffold sample (i). *: p< 0.5; **: p< 0.01; ***: p< 0.001.  
 
Since axonal elongation is important for the formation of functional synapses, we 
further stained with anti-Tau antibodies (Sigma-Aldrich, MO) to specifically label axons. 




10.57 (n=37) and 231.35 ± 17.69 (n=30) µm for the control, nanoprotrusions, and 
nanoladder groups, respectively. As shown in Fig. 2.7 d, the directional axonal length in 
the nanoladder group (blue) is significantly longer (p = 2.02 × 10-4) than the axonal length 
in the control group (black), which is consistent with the dendrite growth results obtained 
from MAP2 staining. In addition, axons on the nanoladder scaffold also follow the 
direction of the micronstripes (arrow shown in Figure 2.7 c). Collectively, these results 
confirm that the nanoladder scaffold promotes the directional growth of dendrites as well 
as axons from embryonic neurons.  
 
Figure 2.7. Axonal elongation of embryonic neurons cultured on the nanoladder scaffold 
confirmed using anti-Tau as the axon marker. Anti-Tau antibody stained embryonic neuron 




arrow indicates the direction of the nanoladder scaffold. (d) Analysis of axonal lengths measured. 
*: p< 0.5; **: p< 0.01; ***: p< 0.001.  
 
2.5 Nanoladder interfacing with ex vivo injured spinal cord tissue model 
 Since nanoladders can successfully guide the neurite growth of embryonic neurons, 
we then evaluated the potential of the nanoladder scaffolds in facilitating and, more 
importantly, directing neurite regeneration after injuries. We used organotypic spinal cord 
cultures as a simplified model for injured neurons.[138] We first characterized the growth 
pattern of individual slice cultured on two different substrates: the cover glass as a control 
group and the nanoladder group. Slices with 250 µm thickness were extracted from the E15 
rat embryonic spinal cord and seeded onto the substrates. After culture for 10 days, we 
used anti-SMI31 (EMD Millipore, MA) to stain neurofilament to characterize regenerating 
axon bundles. As shown in Figure 2.8 a and b, the slices exhibited outgrowth of axonal 
fibers in both groups. However, growth manners were significantly different. In the control 
group, we found random outgrowth of neuronal fibers in all directions, which formed an 
interconnected mesh with limited expansion. In contrast, the nanoladder scaffold guided 
the directional growth and expansion of the regenerating axons. We also quantified the 
maximal regenerating axon length by manually choosing the center of slices as the starting 
point and measuring the distance between the starting point to the end of the longest axons 
expansion. As shown in the Figure 2.8c, the average maximal regenerating axon expansion 
in the nanoladder group was found to be 1872 ± 464 µm (n=10 slices), exceeding 1-




slices) measured in the control group (p = 2.54 × 10-6). These results suggest that the 
nanoladder scaffolds facilitate axonal regeneration from a single spinal slice and further 
expansion in a predefined direction.  
Furthermore, to evaluate whether nanoladder scaffolds can promote neuronal 
reconnection after injury, we placed slices in pairs at a distance of 1.0 to 1.5 mm. Such 
distance is known to impair functional reconnection under normal conditions [139] and 
provides an opportunity to test if the nanoladder could meet the clinical needs. After culture 
for 10 days, the slices were fixed and stained with SMI31. On the cover glass (Figure 
2.8d), slice pairs showed a similar interconnected mesh pattern, as previously seen in single 
slices, with no visible connection between the slice pairs. By comparison, in the nanoladder 
group (Figure 2.8e), with the pair of the slices placed parallel to the orientation of the 
nanoladder, the regenerating axons followed the guidance of the nanoladder and 
morphologically connected onto the other slice. Our data suggest that the directional 
outgrowth of axons on the nanoladder scaffold efficiently promotes the neuronal network 






Figure 2.8. Nanoladders facilitate regeneration and neuronal network reconnection 
between organotypic spinal cord slices. (a,b) Immunofluorescence staining images of the spinal 
cord tissue slices cultured on the cover glass as a control group (a) and on nanoladder scaffolds (b), 
respectively. The arrow shows the direction of the nanoladder scaffold. (c) Data analysis of the 
maximum regenerated axonal lengths of the control and nanoladder groups. (d,e) 
Immunofluorescence staining images of a pair of the spinal cord tissue slices cultured on the cover 
glass (d) and on nanoladder scaffolds (e), respectively. ***: p< 0.001. 
 
2.6 Electrophysiology measurement on spinal tissue slices pairs  
 The observed morphological connections set the basis of synaptic connection. 
Thus, we asked whether the nanoladder scaffold promoted functional connections between 
the slices. The experiment design is shown in Figure 2.9a and b. The slices were cultured 




1.0 to 1.5 millimeters, measured from differential interference contrast images, were 
selected for recording. We used a stimulation electrode to stimulate the left slice of a chosen 
pair and performed local field potential recordings on both left and right slices 
simultaneously. To characterize the stimulated response, we delivered four 0.2 ms, 170 nA 
current stimulation at an interval of 0.5 seconds to the left slice. In both control and 
nanoladder groups, the stimulated slice showed robust evoked potential (black curves in 
Figure 5c and d). As shown in the representative trace of the local field potential recordings, 
the unstimulated slice on the right side of the control group showed no detectable response 
to the stimulation on the left slice (red curve in Figure 2.9c). In contrast, in a representative 
trace of the nanoladder group, the unstimulated slice displayed evoked potential to the 
stimulation (red curve in Figure 2.9d), indicating that the slices had regenerated axons 
synapsing with each other and formed active connections that supported the propagation 
of electric signals. In addition, we observed a similar electrical response when the position 
of the stimulator was switched from the left slice to the right one (Figure 2.10), which 
further confirmed the functional connection between the pair of the slices. Collectively, 
our data support that the nanoladder scaffold facilitates functional connections in injured 





Figure 2.9. Electrophysiology confirms the restoration of neuronal connection. Local field 
potential measured from embryonic spinal cord slice pairs cultured on the cover glass and on the 
nanoladder scaffolds, respectively. (a,b) Schematic of the experimental setting for dorsal 
stimulation. (c,d) Bursting local field potential entrainment by dorsal electrical stimulation of a pair 
of spinal cord slices on the control (c) and nanoladder scaffolds (d). Dots represent the onset of 






Figure 2.10. Electrophysiology results when the position of the stimulator was changed. 
(a,b) Schematic of the experimental setting for dorsal stimulation. The stimulator was moved to the 
slice on the right side. (c,d) Bursting local field potential entrainment by dorsal electrical 
stimulation of a pair of spinal cord slices on the control (c) and nanoladder scaffolds (d). Dots 
represent the onset of each burst. 
 
Unlike neuronal cultures, spinal cord tissue culture contains glial cells in addition to 
neurons.[140-141] Glial cells play a major role in supporting the growth and signal 
transduction of axon bundles. Towards understanding the mechanism behind the 
interactions between the nanostructures to the neuronal cells, we explored how glial cells 
in the organotypic slice culture can contribute to the formation of functional connections 
on the nanoladder scaffolds.  
To identify glial cells, we used a specific marker, glial fibrillary acidic protein (GFAP, 




cytoskeleton. We observed a significant expansion of glial cells on the cover glass via 
immunofluorescence staining, shown in Figure 2.11a, b. The regenerated axon bundle is 
expected to grow on top of the glial cell layer and was confirmed by SRS imaging by tuning 
the Z position of the focus lens. As shown in the SRS images in Figure 2.11c, d, there are 
two layers of cells co-localizing. The cells at the bottom layer were at a spherical shape, 
which was identified as glial cells, while the elongated cells at the top layer appeared to be 
neurons.  
 
Figure 2.11. Immunofluorescence staining and SRS images of spinal cord tissue slices 
cultured on the surface of different scaffolds. (a,b) Immunofluorescence staining images of a 
pair of slices cultured on the cover glass and labeled with SMI-31 for the neuronal filaments (a) 
and GFAP for the glial cells (b). (c,d) SRS images of the cultured tissue slices on the nanoladder 




The SEM images (Figure 2.12) of the culture on the nanoladders further revealed the 
directional guidance effect of the nanoladder scaffolds to glial and neuron cells. Influenced 
by the nanoladder, the glial cells attaching to the tip of the nanoprotrusions exhibited a 
directional and elongated manner of growth (Figure 2.12a). The aligned glial cells further 
guided the neuronal regeneration along the direction of the nanoladders in the organotypic 
tissue slice cultures (Figure 2.12b).  
 
Figure 2.12. SEM images of glial cells (a) and neuronal axons (b) from spinal cord tissue 
slices culture on the nanoladder scaffold. 
 
To confirm the above observations, we studied the interaction between the glial cell 
and primary neuron co-cultured on the nanoladder scaffold. To prepare the co-culture, glial 
cells from the P3-5 neonatal rat brain were first seeded onto either cover glass or 
nanoladder scaffold. Different from the cell cultures discussed above, we did not coat the 
substrates with Poly-D-Lysine for co-culture. Therefore neurons are expected to grow on 




then seeded on top of the existing glial cell layer. We stained for anti-Tau (red) and GFAP 
(green) to identify axons and glial cells, respectively. In the control group shown in Figure 
2.13a-c, both glial and neuron cells grew randomly without preferred orientation. On the 
contrary, in the nanoladder group, the GFAP positive cells, possibly astrocytes, were 
partially oriented by the nanoladder scaffolds (Figure 2.13d), which guided the neuron 
cells on top to follow the direction of nanoladder. Co-localization of the orientation of the 
nanoladders, oriented glial cells, and axons was observed in Figure 2.13f. These results, 
together with the previous observations from the organotypic tissue slices culture, suggest 
that the nanoladder scaffolds promote the regeneration of axons via guiding the growth of 
glial cells. 
 
Figure 2.13. The alignment of glial cells helps directional neuronal regeneration on the 
nanoladder scaffold. GFAP labeled glial cells (a,d), anti-Tau labeled neurite in the glial cells and 






 In this work, we developed a nanoladder scaffold to mimic the native organization 
of axon bundles to guide directional neurite outgrowth and functional reconnection over a 
distance of 1 millimeter. We have demonstrated significant neurite directional elongation 
in parallel with the nanoladder direction via culturing embryonic neuron cells on the 
nanoladder scaffolds. We further showed morphological and functional reconnections 
between a pair of the slices placed over 1 millimeter by introducing organotypic spinal 
cord tissue slices as the injury model. We also investigated the influence of nanoladder 
scaffolds on non-neuronal cells, such as glial cells. Our results indicate that nanoladder 
scaffolds enable directional outgrowth of the glial cells in the organotypic spinal cord slices 
as well as the glial and neuron co-culture. 
We note that various neuron-material interfaces have been reported. The majority of 
these platforms can be specified in two categories: micron-scale [142-143] and nanoscale 
structures.[144] Micro-structures, such as grooves, pillars, posts, pyramids, and 
isotropically-etched cavities, in the range of 1 to 200 µm, were utilized for directing neural 
growth.[145] Nanostructures, such as nanotubes, nanopillars, and nanowires, were reported 
to restore the native extracellular matrix organizations to facilitate neuronal regeneration 
after injuries.[146-148] Here, we show for the first time that directional axonal outgrowth and 
regeneration achieved on a single scaffold using segregated organotypic spinal tissue slices 
placed over 1 millimeter apart. Such distance is relevant to many currently used spinal cord 
injury models.[149]  The ability to guide directional regeneration in the millimeter scale 




treatment. We attribute this capability to the unique integration of two structures on our 
nanoladder scaffold, which are the micrometer-wide stripes that guide the growth of 
neurons and the nanometer-scale protrusions that promote the formation of neurites.   
We also note that nanotubes have been successfully used to facilitate nerve electric 
signaling in the spinal cord.[150]  The multiwall carbon nanotubes were used independently 
and integrated with other materials to help stimulate neuronal recovery.[151] In particular, 
Ballerini and coworkers demonstrated the re-formation of neural networks on the nanotube 
platforms to support the reconnection of segregated spinal cord segments.[129] The authors 
also commented that the conductivity of the materials could enhance the 
electrophysiological activities of the injured tissue and create artificial bridges to restore 
electrical connectivity.[148] Notably, such connectivity is not cell specific. More 
importantly, the use of a conductive carbon nanomaterial matrix may introduce 
unnecessary spontaneous activities and electric connections to influence nerve activities, 
which could potentially cause major side effects such as chronic pain. The non-
conductivity of our SiO2 based nanoladder scaffold ensures that all electric connectivity is 
truly formed by cell-specific synaptic connections.  
Another advantage of SiO2 is its biocompatibility. Unlike silicone, stainless-steel 
elements, or platinum-iridium electrodes that are ultimately rejected by the human 
organism [152], SiO2 has been widely used as drug delivery vehicles in vivo, which shows 
high compliance with the cells and tissues.[153] With established surface chemistry, SiO2 
can be functionalized with growth factor and extracellular matrix molecules to further 




prepared on non-transparent silicon wafers [100, 127], neurons or tissues can be directly 
cultured on the SiO2 based nanoladder substrates for live cell optical imaging. Such 
volatility opens up the potential of using the nanoladder scaffold as a platform to 
understand cell-nanotopography interactions. 
Finally, our study provides a foundation for developing a 3D nanoladder structure for 
spinal cord injury repair in vivo.  It was reported that 3D interconnected and addressable 
nanoelectronic networks can be fabricated from ordered 2D nanowire nanoelectronic 
precursors through conventional lithography.[155-156] Such technology provides 
opportunities to couple nanoladder scaffolds with other soft materials, such as hydrogels 
and polymer materials, to fabricate injectable 3D structures.[157-159] Further study along this 
direction promises broad applications in clinical spinal cord injury treatment and brain-
computer interface development. 
2.7 Summary 
A nanoladder scaffold, composed of parallel aligned micrometer-wide stripes and 
nanoprotrusions on the striped surface, was demonstrated for the directional outgrowth of 
neurons. Embryonic neurons cultured on the surface of the nanoladder scaffolds 
established an elongated directional outgrowth. The average neurite length of the 
nanoladder group is 1.7 times longer than that of the control group.  In total, 79.12% of the 
neurites from the neurons cultured on nanoladder scaffolds were distributed within the 
angle in the range of -30˚ to 30˚, towards the orientation of the nanoladder scaffolds. The 




using organotypic spinal cord slices as an ex vivo injury model. Enhanced morphological 
and functional reconnections were obtained for pairs of the spinal cord tissue slices placed 
in the distance of 1 to 1.5 millimeters along the nanoladder scaffolds. Further imaging 
studies revealed that the directional growth of glial cells pre-guided the regeneration 
process. In all, the nanoladder scaffold presented in this work offers a novel platform for 
studies of neuronal development, neuro-glial interaction, and has the potential for 




CHAPTER 3: Self-folding 3D silk biomaterial rolls to facilitate axon 
and bone guidance 
	
Biomaterial scaffold designs are needed to offer self-organizing features related to 
tissue formation while also simplifying the fabrication processes involved.  Towards this 
goal, we report silk protein-based self-folding scaffolds to support cell culture in 3D, while 
providing directional guidance and promotion for cell growth and differentiation. A simple 
and robust one-step self-folding approach was developed using a bilayer hydrogel and silk 
film in aqueous solution. The 3D silk rolls, with patterns transferred from the initially 
prepared 2D films, guided the directional outgrowth of neurites, and also promoted the 
osteogenic differentiation of human mesenchymal stem cells (hMSCs). The osteogenic 
outcomes were further supported by enhanced biomechanical performance. By utilizing 
this self-folding method, the coculture of neurons and hMSCs was achieved by firstly 
patterning each cell type on a 2D silk film and converting it into a 3D format within the 
rolls, mimicking aspects of the structure of osteons, and providing physiologically relevant 
structures to promote bone regeneration. These results demonstrate the utility of self-folded 
silk rolls as efficient scaffold systems for tissue regeneration while exploiting relatively 






Tissues are complex systems that house cells which communicate in a heterogeneous 
environment. Ideally, for successful tissue regeneration, bioengineered 3D scaffolds should 
provide features to promote cell growth and facilitate functional recovery, including: (1) 
adaption of the intrinsic 3D geometry, extracellular matrix (ECM) structure and chemistry 
of the target tissue, (2) biocompatibility, (3) adequate biomechanics to support tissue 
growth and function, with biodegradation at a rate commensurate with new tissue 
formation, to transfer mechanical load, and (4) support for heterogenous cell growth. To 
address these needs, hydrogels have been widely used to support 3D cell growth [160-161].  
With embedded cells inside the hydrogels, these building blocks can be patterned to enable 
3D tissues.  Mixtures of culture medium and growth factors can be added to each building 
block, enabling heterogeneous cell cultures towards tissue-related outcomes. However, due 
to their relatively rapid degradation and poor mechanical properties with respect to 
orthopedic needs, hydrogel-based scaffolds often cannot support sustained cell growth and 
functional tissue formation.  3D-printed scaffolds have also emerged, including integrated 
polymers and inorganic systems, to provide structural control in 3D formats [162-164]. To 
achieve 3D cultures, these scaffolds are traditionally printed to mimic tissue geometry, 
followed by culturing a mixture of cells inside the printed scaffolds. In this approach, 
controlling the spatial distribution of each cell type is challenging. By mixing the cells with 
the printing precursors prior to deposition and crosslinking, the distribution of cells can be 
controlled within the scaffolds [165-166]. However, the crosslinking conditions often limit the 




technology continues to suffer from limits in spatial resolution, and thus nanoscale features 
in ECM systems cannot be duplicated in 3D printed scaffolds.   
Self-folding is an effective approach to generate scaffolds enabling cell patterning in 
3D formats [168]. Self-folding techniques rely on the different hydrophilicity of materials in 
aqueous solution, with and without external thermal stimulation [169-176]. For example, self-
folded tubes were developed by using a modified gelatin gel as the hydrophilic layer and 
polycaprolactone as a hydrophobic portion, at room temperature [177]. Multi-layered 
systems of p(N-isopropyl acrylamide- acrylic acid)/benzophenone acrylate/polyethylene 
glycol (PEG) self-folded at 33℃, close to physiological conditions [178]. Chemical surface 
functionalization with PEG was used to define the cell patterning.  Cells do not adhere to 
the PEG coated surface, which can limit cellular interactions and communication between 
the cells that are separated by the PEG-coated areas. Like the 3D printing of gels, cross-
linking steps are required for most synthetic polymers, which again limits the choice of cell 
types that can be used in the process.  
The objective of the present work was to exploit self-folded silk protein rolls (SRs) as 
scaffolds for functional tissue regeneration. Silk has been widely used in tissue engineering 
and regeneration [179-181] due to its biocompatibility, controllable biodegradability,[182-183] 
tunable biomechanical properties, [184-185], and low inflammatory effects [186]. To enable the 
self-folding process, we used silk fibroin as the hydrophobic layer and coupled this with 
hydrogels as the hydrophilic layer. These rolled structures are unique in mimicking the 
layered cylindrical structures of tissues, in particular bone osteons. This self-folding 




structures critical for successful tissue regeneration. Topological patterns can be introduced 
to the 3D scaffolds through initial patterning the 2D silk films with spatial features at the 
micron or nano scales. In this work, micron-scale stripe patterns, previously found to be 
effective topographical cues to promote cell growth and provide directional guidance [118], 
were fabricated into the silk films to obtain patterned silk rolls (pSRs). Heterogeneous cell 
co-cultures with different cell types defined at specific locations in 3D structures can also 
be achieved through initial patterning the 2D silk film with cells using microfluidic, 
followed by self-folding. SRs were evaluated for utility in neuronal and bone regeneration. 
Embryonic cortical neurons were cultured with the SRs and pSRs and exhibited directional 
growth by the pSRs. Organotypic spinal cord tissue slices, used as an ex vivo model for 
spinal cord injuries, were further cultured on both SRs and pSRs. With the directional 
guidance provided by pSRs, connections were formed between pairs of spinal cord tissue 
slices, placed 2-3 mm away, indicating potential for spinal cord-related biomaterial needs. 
Osteogenic differentiation of human mesenchymal stem cells (hMSCs) was used as the 
model system for bone, where differentiation and enhanced calcium deposition was 
supported on the SRs and pSRs. Importantly, by integrating microfluidic-based cell 
patterning and self-folding, 3D heterogeneous cell cultures with neurons and hMSCs were 
demonstrated, with each cell type at the desired location in 3D, to mimic aspects of the 
osteon structure in the bone unit. Collectively, the self-folding 3D silk rolls provided linear 
guidance and promotion for cell growth through the surface patterning, offered new 
triggers for differentiation, and enabled 3D patterning of heterogeneous cell cultures 




3.2 Methods  
3.2.1 Materials 
The photoresist S1318, SU8, and MF319 developer were purchased from Electronic 
Materials, MA. Poly-D-lysine, penicillin/streptomycin, bovine serum albumin (BSA), 
Triton X-100, OsO4, strychnine, and bicuculline were purchased from Sigma-Aldrich 
Chemical Co, MO. Glutamine-Dulbecco’s Modified Eagle Medium (DMEM), neurobasal 
medium, B27, N2, glutamine, anti-MAP2, anti-Tau, anti-chicken secondary antibody, and 
goat anti-mouse antibody were purchased from Thermo Fisher Scientific Inc., MA. 
Trypsin/ethylenediaminetetraacetic acid (EDTA) and phosphate-buffered saline (PBS) 
were purchased from VWR, PA. Fetal bovine serum (FBS) and horse serum (HS) were 
purchased from Atlanta Biologicals, GA. All other chemicals are purchased from Sigma-
Aldrich without further purification. 
3.2.2 Silk fibroin synthesis 
The silk fibroin solution used for the silk roll fabrication was prepared using the 
protocol previously established by Kaplan group [187]. Briefly, pieces of Bombyx Mori 
cocoons were boiled in 0.02 M aqueous Na2CO3 for 30 minutes. The degummed silk was 
extensively rinsed in distilled water, dried overnight, and dissolved in 9.3 M LiBr at 60 °C 
for 4 hours. The silk/LiBr solution was dialyzed against distilled water for 2 days with 10 
changes of water. The solution was centrifuged at 9,000 rpm for 2 × 20 min. For the 
subsequent silk roll fabrication, the silk concentration was determined using an analytical 





3.2.3 Silk roll fabrication 
The bilayer silk films are made by coupling agarose layers and silk layers. A bilayer 
film was first fabricated on a cover glass by drop-casting agarose (1%)  and silk solution 
(1 - 4%) sequentially and then immersed in an 80% methanol solution to ensure its 
insolubility [188]. The bilayer film will be cut to control the size and aspect ratio on the cover 
glass at dry state. The self-folding can be achieved by peeling the film off from the cover 
glass and immersing in water at 37 °C.  
3.2.4 Fabrication and characterization of patterned silk rolls 
All fabrications were carried out in the Optoelectronic Processing Facility at Boston 
University.  Silicon wafers (P-type, <100>, Addison Engineering, Inc.)  were cut into 
substrates in the size of 20 mm × 20 mm. Silicon substrates were cleaned through multiple 
steps of solvent rinse, in the sequence of toluene, acetone, isopropanol, and deionized water 
before the photolithography process. For the photolithography, photoresist S1813 was 
spin-coated onto the cover glasses, at a speed of 4000 rpm/s for 45s to get a thickness 
around 1 µm. After the silicon substrates were soft baked at 98 °C for 180 s, they were 
exposed to UV light by using a mask aligner (MA6, Suss) with an exposure power of 10.0 
mW for 8 s, followed with post-baking for 2 minutes at 118°C. The developing process 
was carried out by applying the MF319 developer. Then, the micronstripes were fabricated 
onto the silicon substrates via DRIE (STS-ASE DRIE). For the DRIE process, the etching 




used C4F8 with a flow rate of 150 sccm for 1.5s. Chamber pressure was set to be 18 mTorr 
for etching step and 9 mT for the passivation step. For the radio frequency (RF) power was 
set for 1.1 kW for etching step and 0.75 kW for the passivation step. A high-frequency 
mode of 13.56 MHz was used. A platen power was fixed for 40 W for etching step and 10 
W for the passivation step. 300 cycles were used to reach an etching depth of ~ 35 µm.  
3.2.5 Animal 
Embryonic day (E) 14−16 rats, obtained from female, pregnant Sprague−Dawley rats 
bred were used. All animal care was carried out in accordance with the National Institute 
of Health Guide for the Care and Use of Laboratory Animals (NIH Publications No. 80−23; 
revised 1996) and was operated under the protocol 000197 approved by Boston University 
Animal Care and Use Committee. 
3.2.6 Embryonic neuron and spinal cord tissue slices culture. 
All substrates used in the embryonic neuron cell cultures were immersed in 0.01% 
Poly- D-Lysine (Sigma-Aldrich, MO) overnight at 4 °C and washed in PBS before culture 
initiation. Primary spinal cord neurons were obtained from Sprague−Dawley rat E15 
embryos. The spinal cords were isolated and placed in the L15 medium. Meninges were 
removed and spinal cords were cut into small pieces, dissociated by incubation in 0.05% 
trypsin/ethylenediaminetetraacetic acid (EDTA, VWR, PA) 15 min at 37 °C and triturated 
every 5 min. Dissociated cells were washed with and triturated in 10% heat-inactivated 
fetal bovine serum (FBS, Atlanta Biologicals, GA), 5% heat-inactivated horse serum (HS, 
Atlanta Biologicals, GA), 2 mM Glutamine-Dulbecco’s Modified Eagle Medium (DMEM, 




for 30 min at 37 °C to eliminate glial cells and fibroblasts. The supernatant containing 
neurons was collected and seeded on poly-D-lysine coated cover glass and incubated in a 
humidified atmosphere containing 5% CO2 at 37 °C with 10% FBS + 5% HS + 2 mM 
glutamine DMEM. After 16 h, the medium was replaced with Neurobasal medium 
(Thermo Fisher Scientific Inc., MA) containing 2% B27 (Thermo Fisher Scientific Inc., 
MA), 1% N2 (Thermo Fisher Scientific Inc., MA), and 2 mM glutamine (Thermo Fisher 
Scientific Inc., MA). 
For organotypic tissue culture, spinal cords or cortex from Rat E15 embryos were 
isolated and sliced into slices in the thickness of 250 µm with a tissue slicer. Slices were 
then placed on nanoladders or cover glasses. Organotypic slices were cultured with 1 mL 
of medium containing 67% DMEM, 8% sterile water, 25% fetal bovine serum, and 25 
ng/mL nerve growth factor; adjusted to 300 mOsm and pH 7.35; and incubated in a 
humidified atmosphere containing 5% CO2 at 37 °C for 7 to 14 days before fixation, 
staining, and imaging. 
3.2.7 hMSCs culture. 
Prior to cell seeding, silk rolls were sterilized by being immersed in 70% ethanol and 
treated with UV under the fume hood for 1 hour. They were then coated with 0.1% gelatin 
overnight at 37℃ in an incubator and washed three times with PBS. Human Mesenchymal 
Stem Cells (hMSCs) (passage number < 5) were seeded into the silk rolls using a cell 
suspension with a density of 100 x 103 cells/mL. The rolls were then transferred into a fresh 
well containing 2,500 cells/mL and left in growth medium (DMEM high glucose 




(Gibco), 1% Non-Essential Amino Acids (Gibco) and 5ng/mL basic fibroblast growth 
factor (Gibco)). After 2 days in growth medium, the medium was either replaced with fresh 
growth medium or with osteogenic medium and changed every 2-3 days for the duration 
of the study. Osteogenic medium consisted of DMEM high glucose GLUTAMAX (Gibco), 
10% Fetal Bovine Serum (Gibco), 1% antibiotic-antimycotic (Gibco), 100 nM 
dexamethasone (Sigma-Aldrich), 10 mM sodium β-glycerophosphate (Sigma-Aldrich), 
0.05 mM L-Ascorbic acid and 5ng/mL basic fibroblast growth factor (Gibco). 
 
3.2.8 Neuron/hMSCs coculture 
For the coculture, the half-patterned silk films were drop-casted onto a half-patterned 
silicon substrate. A PDMS compartment was mounted onto the silicon substrate to form a 
device for the coculture. The whole device was immersed in 70% ethanol under UV light 
in a fume hood for 1hr for sanitizing. The device was coated with 0.01% PDL/LMN for 
neuron culture and 0.1% gelatin for hMSC culture overnight at 37 ℃ in an incubator and 
washed three times with PBS. Neurons and hMSCs were seeded into each compartment 
with a cell density of 3000 cells/cm2 and 5000 cells/cm2 in a coculture medium (Neuron 
basal + 1% N2 + 2% B27 + 1% Glutamax + 1% p/s + 1% non-essential amino acid + 1 
ng/mL nerve growth factor) [189], in a humidified atmosphere containing 5% CO2 at 37 ℃ 
for 7 days before fixation, staining and imaging . 
3.2.9 Immunofluorescence staining and confocal imaging.  
To track neurite outgrowth, cells were fixed with 4% paraformaldehyde for 20 min. 




30 min and permeabilized with 0.2% Triton X-100 (Sigma-Aldrich, MO). Then cells were 
incubated with mouse monoclonal anti-Tau (1:1000) antibody for 2 h, and then with goat 
anti-mouse antibody (1:1000, Thermo Fisher Scientific Inc., MA) for 1 h at room 
temperature. The IF images were taken using a confocal microscope (Olympus, FV1000). 
3.2.10 ALP activity assay. 
Early osteogenic differentiation of the hMSCs was evaluated by measuring the Alkaline 
Phosphatase (ALP) activity after 21 days of culture, using Alkaline Phosphatase 
Colorimetric Assay Kit (Abcam, ab83369). Briefly the silk rolls were washed in cold PBS, 
and the cells were treated with 0.2% Triton X 100 (X110, Sigma) for 10 minutes, followed 
by sonication. Samples were centrifuged at 4℃ for 15 minutes to remove insoluble 
materials, and the supernatant was collected and kept on ice. Cell lysates and the assay 
buffer solution (5 mM pNPP) were added to a 96-well plate, incubated for 1 hour, and the 
absorbance was read at 405 nm using a microplate reader. A standard curve was made from 
standards (0–20 µM) prepared with a pNPP solution. The samples and standards were 
analyzed, and sample concentrations were read from the standard curve. To detect ALP 
expression, nitro-blue tetrazolium/indolylphosphate (NBT/BCIP) (Thermo Scientific) 
staining was also performed. Before staining, the cells were washed, NBT/BCIP was added 
and the samples were incubated at 37 °C in a humidified chamber containing 5% CO2. 
After 30 mins, the samples were washed with PBS and imaged using a BZ-X700 series 




3.2.11 Von Kossa staining. 
Late osteogenic differentiation of the hMSCs was assessed using Von Kossa staining, 
using a commercially available kit (Kit KTVKO, American MasterTech). After 5 weeks 
of culture in growth or osteogenic cell culture medium, the silk rolls were rinsed in PBS, 
fixed with 4% paraformaldehyde for 30 minutes, rinsed extensively with distilled water, 
and placed in a 5% silver nitrate solution and exposed to UV light for approximately 1 
minute until a dark staining could be observed. The rolls were then rinsed extensively in 
distilled water, placed for 2-3 minutes in 5% sodium thiosulfate, and counterstained with 
a nuclear fast red stain for 5 minutes. The silk rolls were once again rinsed extensively 
with distilled water before being imaged using a BZ-X700 series microscope (Keyence, 
Itasca, IL). 
 
3.3 One-step self-folding of the bilayer agarose/silk films. 
For the self-folding of films under aqueous conditions, biomaterials with different 
hydrophilicity and swellability are needed. To achieve self-folding, several factors need to 
be controlled: First, stress must be generated in the film. When transferring the bilayer film 
from a dry state to aqueous solution, surface tension is created at the interface. The 
hydrophobic silk layer tends to fold, which provides the main driving forces for the self-
folding process. Meanwhile, the agarose layer absorbs water and expands, which slows and 




concentration and the agarose-to-silk film thickness ratios are parameters that can be 
exploited to control the self-folding process.  
 
 
Figure 3.1. Schematic of the self-folding process. 
 
We initially fixed the thickness of the agarose film, by applying 100 µL 1% w/v agarose 
solution onto 18 ´18 mm cover slips. We then varied the thickness of the silk layer by 
adjusting the volume of a 1% w/v silk solution from 100 to 500 µL, with a step volume 
increase of 100 µL (Figure 3.2a). No self-folding was achieved under these conditions 
(Figure 3.2b). We then increased the concentration of the silk solution to 2% w/v and 4% 
w/v, respectively. As indicated in Figure 3.2c and b, the bilayer films with a silk 
concentration of 2% showed the most efficient folding performance. Self-folding silk rolls 





Figure 3.2 Self-folding process is enabled by controlling the film thickness. (a) Schematic 
of the conditions tested. (b-d) Digital images of changing silk solution concentration from 1% to 
4%. 
 
Collectively, the optimal conditions to maintain the tightest and most stable folding is 
100 µL of 1% agarose solution and 300 µL of 2% silk solution on cover slips of 18 × 18 
mm. This condition resulted in a thickness of the dry bilayer film of 3.15 ± 0.03 µm, 
measured by scanning electron microscopy (Figure 3.3), and corresponding to a wet film 






Figure 3.3. SEM images showing the film thickness of dried bilayer film. Scale bar: 2 µm. 
 
Notably, the choice of the hydrophilic layer in the bilayer design was not limited to 
agarose, as gelatin gels (10% w/v) also produced similar self-folding silk rolls (Figure 3.4).  
 
Figure 3.4. Using 10% w/v gelatin as the hydrophilic layer. Top view (a) and cross-section 




Second, the ratio between the width and length, i.e. the aspect ratio of the films, was 
also important for self-folding. The width of the bilayer films was maintained at 6 mm, and 
the length of the films was changed to tune the aspect ratios to 1:1, 1:2 and 1:3, respectively. 
The number of folding layers is defined as the number of bilayer films found along the 
radius of the silk rolls. As shown in Figure 3.5, 4-layer folding was achieved on the film 
with a 1:1 aspect ratio, resulting in a roll with a total diameter of 0.6-0.8 mm. More folding 
layers were obtained by increasing the aspect ratio: 6 layers from a 1:2 aspect ratio and 8 
layers from a 1:3 aspect ratio, with a diameter that increased to 1.0-1.5 mm. Long-side 
rolling dominated for films with high aspect ratios, while diagonal and all-side rolling 
occurred for films with low aspect ratios. These findings were consistent with previous 
reports[176]. Collectively, the diameter and number of layers formed in the silk rolls can be 
designed and controlled by tuning the aspect ratio of the bilayer films.  
 
 
Figure 3.5 Self-folding strategy for controlling number of layers. Layer number control by 





Additionally, the edges were found to have a slightly higher thickness compared to the 
film center, formed during drying, due to surface tension. We hypothesized that this thick 
edge, in addition to the aspect ratio, could also define self-folding. To test the effect of 
these edges on self-folding, three groups of films were prepared with 3 given aspect ratios: 
no edge, long edge (edges along the long sides) and short edge (edges along the short sides). 
Each condition was repeated to confirm the reproducibility of the self-folding process 
(Figure 3.6). In the group with no edges, folding along the diagonal direction was preferred 
for all aspect ratios. In the long edge group, the presence of the edge regulated the initial 
folding direction, which was along the short side, as indicated by the arrow in the 
schematic, and regardless of the aspect ratio of the bilayer films. For the short edge, for 
aspect ratios greater than 1:3, the folding direction was dominated by the edge effect. 
However, by decreasing the aspect ratio further to 1:4, only the portion of the film that was 
close to the edge folded along the direction of the arrow, while the rest of the film folded 
along the diagonal direction [176]. The folding direction was therefore determined by 
competitive effects attributed to the aspect ratios of the film and the edge effects. 
Specifically, the edge determines the initial folding direction, and a diagonal folding is 
more favored in the no edge area. Collectively, the self-folding can be controlled by 






Figure 3.6 Repeated self-folding processes was achieved by tuning aspect ratio and edge 
effects. 
 
3.4 Fabrication of patterned silk rolls.  
Patterned topographical cues can modulate cell growth[15, 93, 100]. A micron-stripe 
pattern guides the directional growth of axons and can promote axonal growth, as we have 
previously reported [118]. This modulated growth facilitated functional connection of 




make the pSRs, we first fabricated micron-stripe patterns on silicon wafers as a mold. The 
patterns were a set of 20 µm stripes with 20 µm spacing, as previously shown to guide and 
promote axonal growth [118]. Deep reactive ion etching (DRIE) was used to control the 
depth of the patterns on the silicon substrate, to ensure that the patterns could be transferred 
onto the bilayer films [190]. As shown in Figure 3.7a and b, the patterns on the silicon 
wafers were successfully fabricated with a depth of 31.63 ± 1.56 µm. By casting silk fibroin 
on the patterned silicon surface, as confirmed by SEM, pSRs with micron-stripe patterns 
were transferred onto both sides of the film (Figure 3.7c and d). As shown in Figure 3.7e 





Figure 3.7. Pattern design on the self-folding silk roll and biomechanical properties. (a,b) 
SEM images of top view (a) and cross-section view (b) of the Si mold. (c,d) SEM images of the 
patterned transferred onto the agarose layer (c) and silk layer (d) (e) SEM images of the patterned 
silk rolls. Scale bar: 50 µm. (f) Optical images of patterned silk rolls. Scale bar: 200 µm. 
 
3.5 The patterned silk rolls facilitated the direction growth of the axon.  
First, we showed that SRs as 3D scaffolds were compatible with neuron cultures. Rat 




the SRs were precoated with poly-d-lysine (PDL). Cell seeding was achieved through the 
capillary effect of the SRs (Figure 3.8).  
 
Figure 3.8. Cell seeding using capillary effect. 
 
The neurons were cultured on the SRs and pSRs for 7 days and then fixed for imaging. 
To visualize the neurons and axons, anti-Tau immunofluorescent (IF) staining was used 
and imaged using confocal microscopy. As shown in the 3D-reconstructed fluorescence 
images (Figure 3a), neurons attached and grew within the SRs, with stained cells detected 




To further validate whether the patterns on the pSRs promoted directional growth of 
neurites, embryonic neurons were seeded into the pSRs and IF staining was used to 
visualize cell growth patterns. In addition, the pSRs were coated with PDL and laminin 
(LMN), respectively, to test the effect of surface coatings on cell growth. Consistent with 
our previous findings on 2D patterned glass or silicon surfaces, directional growth of axons 
was found on the 3D pSRs (Figure 3b). To quantify the growth, morphometric and 
statistical analysis of the confocal images was used. As shown in Figure 3c, the SRs coated 
with PDL had an average neurite length of 301.13 ± 66.18 µm (N=36), while the pSRs 
showed an average neurite length of 580.86 ± 147.51 µm (N=55) for the PDL coating and 
882.77 ± 158.04 µm (N=60) for the LMN coating. The patterns on the pSRs, along with 
the PDL/LMN surface coating, displayed a synergistic effect in facilitating neurite 
outgrowth. An analysis of the directionality of neurite growth was also performed (Figure 
3d, e). The direction of the micron-stripe parallel patterns was defined as 0o and measured 
the angle of the neurites with respect to the pattern direction. As shown in Figure 3d, the 
SRs without surface patterns did not provide directional guidance to the neurons, as the 
angular distribution was uniform in all directions from -90o to 90o. In comparison, in the 
pSRs coated with LMN, over 85% of neurites were distributed between -30o to 30o of the 
pattern direction, indicating a preferred growth direction defined by the micron-stripe 
patterns on pSRs. These results demonstrated that the patterned 3D silk rolls successfully 






Figure 3.9. Silk rolls for neuron culture and facilitate neuron directional growth. (a) 
Reconstructed confocal images of neurons cultured on silk rolls within each layer. (b) 
Reconstructed confocal images (left) of neurons cultured on patterned silk rolls within PDL 
(middle) and LMN coating (right). Scale bar: 20 µm. (c) Neurite length measurement. (d,e) Neurite 





To further highlight the significance of the patterned silk rolls in promoting neuronal 
growth, rat E14-16 embryonic spinal cord tissue slices were cultured with SRs and pSRs. 
The spinal cord tissue slices are widely used as an ex-vivo spinal cord injury model to study 
neuronal regeneration [129]. To stabilize the tissue slices in the silk rolls, two grooves were 
prepared on a silk roll with a width of 400 - 500 µm, and 2-3 mm apart. A 350 µm-thick 
spinal cord tissue slice was placed in each groove in the SRs (Figure 3.10a) and pSRs 
(Figure 3.10e). After 14 days in culture, the slices were stained with anti-SMI31 antibody 
and imaged by confocal microscopy. In SRs, the growth of the tissue slices resulted in 
interconnected neurite meshes around the initially seeded tissues, but no connections were 
formed between the two slices (Figure 3.10 b-d). In pSRs, guided by the patterns, the 
regenerated neural filaments aligned in the direction of the patterns, and connections were 
achieved between the two tissue slices (Figure 3.10 f and g). This is critical for enabling 
electrical signals, as previously demonstrated [118]. More importantly, as shown in the cross-
sectional images along the axial direction of the rolls (Figure 3.10h), the connections were 
established on multiple layers within the pSRs. These results indicated that the rolls 
promote tissue regeneration and reconnection in a 3D environment, with relevance for 





Figure 3.10. Spinal cord tissue slices culture in the silk rolls. (a,e) Schematic of culturing 
spinal cord tissue slices into silk rolls (a) and patterned silk rolls (d). (b-d) Reconstructed confocal 
images of spinal cord tissues cultured on silk rolls with top view (b), zoom-in view (c, indicated by 
the white dash box) and cross-section view (d). (f-h) Reconstructed confocal images of spinal cord 
tissues cultured on patterned silk rolls with top view (f), zoom-in view (g, indicated by the white 




3.6 Preliminary tests of using silk rolls for in vivo SCI treatment. 
With knowing the efficacy of using patterned silk rolls in guiding the directional growth 
of neurons in vitro and ex vivo, we further moved onto the in vivo model and investigated 
whether silk rolls can treat SCI.  
Since cervical contusion SCI is considered as one of the most server injured model with 
highest clinical relevance, a hemi-section animal model at C4-C5 was used here. As shown 
in Figure 3.11a, SD rate (male, ~200g) was weighed and anesthetized for the surgeries. 
Contusion injury was created on unilaterally on one side of the spinal cord, locating at C5-
C8 level. 3 mm spinal cord removal was operated at cervical 5 right side. The silk rolls 
were then implanted. The silk rolls were stabilized in the injured site by suturing 
togethering the dura and opposing muscle layers.  
To determine axonal regeneration mediated by the 3D silk rolls, we focused on one 
major descending pathway: descending propriospinal tract (dPST). The dPST system 
mediates important spinal functions including reflex, posture, and locomotion in normal 
conditions [191]. The greatest numbers of dPST neurons are located in the medial part of 
Rexed lamina VII and VIII [191-200]. These neurons constitute an uninterrupted cell column 
and their axons project bilaterally through the ventrolateral funiculi (VLF) and have a direct 
effect on motoneurons and interneurons in multiple cord segments [191-192, 196-199, 201-203]. The 
dPST neurons above the level of injury receive strong and convergent supraspinal 
innervations and, following a SCI, these dPST axons are either damaged (e.g. after 




BDA to trace the dPST axons can help us to quantify the axonal regeneration in the silk 
rolls after SCI. Therefore, we injected BDA tracer right above the lesion sight 8 weeks 




Figure 3.11. In vivo experiments of SCI treatment by silk rolls. (a) In vivo experiment 
procedures. The location of implanted silk rolls is indicated by the white arrow. (b) The experiment 
flow and time points for the in vivo experiment. The yellow box in a. (c) Stitched images to show 
the cross-section in the implanted region using silk rolls. (d) IF staining on the patterned silk roll 
implanted region. (e) Zoon-in images from the yellow box in d. (f) Stitched images to show the 
cross-section in the implanted region using patterned silk rolls. 
 
As we know there is no spontaneous regeneration can happen at this injured site 51, 




folding and coated with Laminin before implantation. After collecting the tissues, we did 
immunofluorescence staining and confocal fluorescent imaging on the region with silk roll 
implantation. We used anti-SIM31 to label axons, GFAP to indicate astrocytes and S100 
to show Schwann cells. The reconstructed images are shown in Figure 3.12.  
In the silk roll group (Figure 3.12 a-c), very limited axons can grow into the silk rolls 
and a clear boundary formed on the interface between host tissue to the silk rolls. No sign 
of migration of astrocytes and Schwaan cells into the silk rolls, which indicates that the 
environment in the silk rolls are not ideal to attract regenerated axons to grow in and 
regeneration. However, in the pattern silk roll group (Figure 3.12 d-f), on the outer layers 
inside the patterned silk rolls, a high coverage of regeneration axons can be found in the 
anti-SMI31 stained images. More importantly, the axons, displayed in Figure 3.12e, 
showed significant directionality along the orientation of the patterned silk rolls. Migration 
of active astrocytes can be noticed, indicating a positive sign of regeneration, while no clear 
sign of Schwann cells growth in the patterned silk roll. Based on the preliminary data, it is 
suggesting that patterned silk rolls have the potential in promoting SCI, however, more 
systematic studies are needed.  
Another important thing we noticed that the center hole in the silk rolls leaves an empty 
space, in where showed negative effect to the axonal regeneration. Blood and metabolism 
wastes were accumulated in this space to hinder axonal growth. A new strategy that can 
embed the silk rolls in a hydrogel system needs to be investigated to create a more-friendly 






Figure 3.12 Reconstructed confocal images on the harvested tissue 10 weeks after 
implantation using silk roll (a-c) and patterned silk rolls (e-f). (a) IF staining on the silk roll 




3.7 Osteogenic differentiation of hMSCs on the silk rolls. 
The growth and osteoblastic differentiation of human mesenchymal stem cells 
(hMSCs) were assessed on the 3D silk structures to validate their utility as scaffolds for 
bone regeneration. Mesenchymal stem cells for bone regeneration are well-described in the 
literature and crucial for neo-osteogenesis, the formation of new bone at the injured site[206-
207]. From a materials perspective, scaffolds for bone repair should be biocompatible, 
biodegradable and osteoinductive/osteoconductive to promote cellular proliferation and 
osteogenic differentiation. hMSCs were cultured with the as-designed silk rolls to 
investigate whether the SRs promoted the osteogenic differentiation of hMSCs. 
For culturing with hMSCs, SRs and pSRs were coated with 0.1% gelatin to promote 
cell attachment. The cell seeding was achieved by immersing the rolls in a cell suspension 
solution with an initial cell density of 0.1 million cells/mL. Due to the capillary effect, 
hMSCs cells were sucked into the rolls with a final concentration of 3000 – 5000 within in 
the rolls. After one week of culture, the hMSCs were fixed and stained with phalloidin for 
confocal imaging. The cells adhered, spread, and proliferated on all layers of the SRs 
(Figure 3.13a) and pSRs (Figure 3.13b). Unlike the neurons, no directional growth or 
morphological differences of hMSCs were observed on the SRs versus the pSRs scaffolds, 
indicating that the growth pattern of hMSCs was not sensitive to the surface topography 
provided by the pSRs. 
To quantify the osteogenic differentiation of the hMSCs on the silk scaffolds, alkaline 




into osteoblasts[208]. Three groups were designed: plastic culture dish (control group), SRs, 
and pSRs.  The hMSCs were cultured in growth medium (GM) or osteogenic medium 
(OM), to investigate the osteoconductivity and osteoinductivity of the devices. ALP 
activity was normalized to total protein content, determined by the BCA assay. In Figure 
3.13c, in growth medium, the order of ALP enzymatic activity after 21 days of culture was: 
pSRs > SRs > plastic, demonstrating that the silk rolls had a positive impact on the 
differentiation process. In osteogenic medium, all groups showed increased enzymatic 
activity compared to growth medium, with SRs and pSRs showing higher activity than the 
plastic group. In osteogenic medium, ALP activity was higher in SRs compared to pSRs. 
Interestingly, the positive effect of the patterning on ALP activity is less marked in 
osteogenic medium versus growth medium. Nevertheless, the results revealed a synergistic 
effect between osteogenic medium and the silk to promote osteogenesis.  
To assess the quality of the tissue formed within the scaffolds, the biomechanical 
properties of the silk rolls were assessed before and after cell culture (Figure 3.13d). All 
groups were tested in a hydrated state using PBS. For the bare rolls, the compressive 
strengths measured for SRs and pSRs were 0.11 ± 0.04, 0.10 ± 0.05 MPa, respectively, and 
not significantly different. After 35 days of culture with hMSCs, the compressive strength 
of the SRs increased to 0.44 ± 0.21 MPa in growth medium and 0.65 ± 0.11 MPa in 
osteogenic medium. These data support that SRs promoted the osteoblastic differentiation 
of hMSCs, mineral deposition, and increase in biomechanical properties. For pSRs, the 
compressive strength was 0.15 ± 0.03 MPa after 35 days of culture in growth medium, 




compressive strength increased to 1.20 ± 1.14 MPa. These results indicated increased 
calcium deposition in the SR and pSR groups, and suggest that SRs and pSRs are promising 
scaffolds for bone regeneration.   
 
Figure 3.13. Silk rolls as an osteoconductive substrate for hMSCs. (a,b) 3D reconstructed 
confocal images of hMSCs cultured with SR (a) and pSR (b). Scale bar: 500 µm. (c) ALP activity 
analysis. (d) Biomechanical measurement of silk roll. (n.s.: non-significant, p > 0.5; *: p < 0.5; **: 
p < 0.01; ***: p < 0.001.)  
 
Osteogenic differentiation of the hMSC was further confirmed by assessing calcium 
deposition; four groups were cultured for 5 weeks, Von Kossa staining was carried out. As 




osteogenic medium, indicating the successful calcium deposition. All these results 
demonstrate that the SRs can be used for osteogenesis, as an osteoconductive substrate for 
hMSC growth. 
 
Figure 3.14. Von Kossa staining to confirm the osteogenic differentiation. (a,b) Silk rolls 
with hMSCs cultured in growth medium (a) and osteogenic medium (b), (c,d) Patterned silk rolls 
with hMSCs cultured in growth medium (c) and osteogenic medium (d). Scale bar: 500 µm.  
 
3.8 Patterned heterogeneous coculture of neurons/hMSCs on the silk rolls.  
A distinct benefit of these self-folding 3D silk structures is that a heterogenous 3D cell 
culture with different cell types at specific locations can be achieved by patterning cells on 
the surface of the 2D silk film, followed by 2D-to-3D folding. As a proof-of-concept, a 3D 




two cell types in 3D were pre-designed based on their locations on the 2D silk films. A silk 
bilayer film was prepared with part of its surface patterned with micron-stripes and the 
other part smooth. Compartments were then defined using polydimethylsiloxane (PDMS) 
on the surface of the as-prepared silk film to introduce region-specific cell cultures. The 
micron-striped patterned region was coated with PDL for neuron culture, while the smooth 
area was coated with 0.1% gelatin for hMSCs adhesion. After seeding neurons and hMSCs 
into the two regions, respectively, the whole system was incubated overnight to ensure cell 
attachment. Then, the PDMS compartment was removed, the entire silk film was released 
from the silicon wafer and immersed in the culture medium.  (Figure 3.15 a). Self-folding 
of the film was achieved during the cell incubation at 37 ℃, as shown in the schematic in 
Figure 3.15 b. The cells were kept in culture for 7 days. Neurons were stained with anti-
Tau using IF staining, and hMSCs were stained with anti-CD73, to show cell localization. 
Only a portion of the silk rolls was imaged (indicated as the yellow box in Figure 3.15b), 
due to the limitations in focal length of the confocal microscope.  
With spatial separation and location achieved by the PDMS compartments, 
heterogeneous cell cultures were achieved by simply coupling compartments onto the 
bilayer films before the self-folding process and seeding the cells. Additional topological 
structures on the surface of the silk films can be introduced independently.  Neurons were 
cultured on the micron-stripe patterned area for directional growth, while hMSCs were 
grown on the smooth regions of the films. As shown in the 3D reconstructed images from 
top and cross-sectional views along the axial direction of the rolls (Figure 3.15 c, d), 3D 




the self-folding was initiated on the neuron side. Neurons were thus centered in the 3D 
rolls and surrounded by hMSCs, to mimic the structure of osteons. With the advantage of 
simple self-folding, this method is easy to manipulate with no need for further chemical 
modifications. The process is compatible with cell growth conditions, which holds promise 
for expanding the approach to more cell types and more complicated designs, to mimic 
hierarchical tissue conditions.   
 
Figure 3.15. Silk rolls as functional bone segments for nerve and osteogenesis. (a) 
Schematic of heterogeneous cell seeding and co-culture. (b) Schematic of heterogeneous cell 
culture in the self-folded silk rolls. (c,d ) Reconstructed confocal images of co-culture in the silk 
rolls in the yellow dashed region (c) and black dashed region (d), respectively. Left: Top view, 





Starting from agarose/silk bilayer films, 3D silk roll structures were achieved using a 
one-step folding method at 37℃. The self-folding can be designed and controlled by tuning 
film thickness, aspect ratio and edge effects, to produce multi-layer silk rolls with a 
controlled and predictable diameter and number of layers. Topological cues that modulate 
cell growth behavior, such as micron-stripe patterns, can be introduced into the silk roll to 
form patterned silk rolls. We demonstrated that these self-folding concentric multi-layer 
silk rolls can serve as 3D scaffolds for neuron cultures with directional axonal outgrowth 
on the pSRs. 3D spinal cord tissue slices cultured on the multilayer pSRs exhibited 
connections through all layers between slices that were ~2 mm apart. Both of these results 
are critical for functional reconnection in injured neuronal systems. 3D cultured hMSCs on 
the SRs exhibited osteoblastic differentiation and mineral deposition. Heterogenous 3D 
cell cultures with neurons and hMSCs in the silk rolls were achieved with selective cell 
patterning, leveraging the features of SRs including surface structure patterning of 2D 
films, 2D-to-3D conversion, and compatibility with microfluidics. Overall, these self-
folding silk rolls are unique functional scaffolds able to promote directional growth, 
differentiation and regionalized heterogenous 3D culture outcomes, providing potential for 




CHAPTER 4: Optoacoustic neurostimulation by semiconducting 
polymer nanotransducers 
 
Neuromodulation with various methods has been developed to treat neurological 
disease and study fundamental neuroscience. Optogenetics has been established as a 
powerful method to modulate neural activity in rodents. However, it is still limited by its 
invasiveness. Although ultrasound showed potential in non-invasively modulating brain 
activities across species, it suffers from low spatial resolution. To address these challenges, 
we developed an optoacoustic neuro-stimulation platform via surface-modified 
photoacoustic nanotransducers (PAN) to bind onto neurons and generate localized 
optoacoustic waves in the near-infrared second window. Optoacoustic neurostimulation in 
vitro can be achieved with 3ms of laser pulses (10 pulses). In vivo neural stimulation of 
mouse brain and modulation of motor activities was further demonstrated by directly 
injecting PAN into the mouse brain. With enhanced temporal and spatial resolution, PANs 
showed potential in precise control of the neuronal circuits in the brain for basic 
neuroscience studies and treatment of neurological disorder diseases. 
 
4.1 Introduction 
Neuromodulation has been an invaluable approach for studying neural circuits and 
treating neurological diseases. Of all the developed neuromodulation techniques, electrical 




procedure and long-term side effects of the implanted electrodes poses significant risks for 
patients [209]. Noninvasive clinical methods such as transcranial magnetic stimulation 
(TMS) [210] and transcranial direct current stimulation (tDCS) [211] do not require a surgical 
procedure but offer a poor spatial-temporal resolution. Ultrasound is an emerging 
neuromodulation technique that offers the potential to non-invasively modulate brain 
activity across species [82-83]. Transcranial focused ultrasound has been demonstrated to 
evoke a motor response in mice [83-84], rabbits [85] and, significantly, sensory/motor 
responses in humans [86-87]. The skull will reflect the acoustic wave and compromise 
ultrasound focus, resulting in a limited spatial resolution of a few millimeters similar to 
TMS and tDCS. Optogenetics has been a powerful method capable of modulating 
population neural activity in rodents [72-73], whereas the requirement of viral infection needs 
additional animal preparation, prevents its use in broader fundamental studies, and limits 
its application in humans [74]. 
Nanotechnology has offered some promising alternative neurostimulation approaches. 
Gold nanoparticles and nanorods are most studied for photothermal neural stimulation in 
vitro [109-110]. Tian and Bezanilla groups reported photoelectrical stimulations with silicon 
nanostructures [113]. In this case, wavelengths of light used are in the range of 520 – 808 
nm, which has limited penetration in highly scattered skulls and brain tissue. To increase 
penetration depth, Pu group demonstrated photothermal neural stimulation using 
bioconjugated polymer nanoparticles binding to transient receptor potential cation channel 
subfamily V member 1 (TRPV1), which has absorption at in the NIR window[111]. 




nanoparticles in TRPV1 overexpressing mice, and achieved transcranial magnetothermal 
stimulation[114]. In these studies, local temperature was required to be increased to 43 ˚C to 
reach the thermal-stimulation threshold, raising concerns over safety issue of thermally 
activated brain stimulation. Additionally, the requirement of genetic modification limits 
their application in human subjects.  
In our work, we developed an optoacoustic semiconducting polymer nanotransducers 
(PAN) to enable neurostimulation using a nanosecond laser at the NIR-II window, aiming 
to achieve improved temporal-spatial resolution with high efficiency. (Figure. 4.1). PAN 
was shown to generate ultrasound by an optoacoustic process upon unique excitation of 
NIR-II nanosecond pulsed light [212]. Such wavelength (1000-1700 nm) has been 
demonstrated to have the capability of deep tissue penetration depth [213],[214], compared 
with the visible light used in optogenetics and all the other nanostructures used for 
neurostimulation. To facilitate binding of PAN to neurons, we have designed two different 
surface chemical modifications of PAN including charge-charge interaction and specific 
targeting to mechanosensitive ion channels. Upon light excitation, the PAN on the neuronal 
membrane goes through transient heating and thermal expansion, generating acoustic 
waves at the the neuronal membranes by PAN consequently perturb membranes locally, 
resulting in depolarization of the membrane. Here, we show for the first time that a 
nanostructure with the capabilities to generate optoacoustic signal substantially, can be 





Figure 4.1. Design principle of the PAN induced neurostimulation. 
 
Notably, different from photothermal stimulation, the laser pulse width of the PAN is 
3 ns. Using such a short laser pulse, the heat generated by the laser will be confined inside 
the PAN, which will produce thermal expansion and generates acoustic waves with smaller 
temperature increase in the surrounding medium, compared to photothermal stimulation, 
where continuous wave light with a pulse width longer than 1 µs is used. (Fig. 4.2). At the 
same laser power condition, our in vitro studies showed a much higher efficiency achieved 
through PAN based photoacoustic neurostimulation, compared to the photothermal 





Figure 4.2. Design principle of the PAN induced neurostimulation. 
 
4.2 Methods  
4.2.1 Material  
All chemical reagents were purchased from Sigma-Aldrich (MO, USA) unless 
otherwise stated. SPs was synthesized via palladium-catalyzed C–C cross-coupling 
techniques and was thoroughly purified to remove any metal residues. The TRPV4 
antibody powders were purchased from Aloemone lab without further modification. 
4.2.2 Characterization 
SEM images were obtained on a Zeiss Supra 55 scanning electron microscope with an 
accelerating voltage of 3 kV. A sputter coater, Cressington 108, was used to coat a layer of 




performed on Brookhaven 90plus nano-particle sizer with zeta potential. UV-Vis-NIR 
spectra were recorded on Cary 5000 spectrophotometer. FT-IR spectrum was taken on 
Bruker Optics Vertex 70v FTIR, equipped with Hyperion microscope and Silicon 
Bolometer. 
4.2.3 Synthesis of PAN 
The synthesis process of PAN has been reported previously [212]. SPs were dissolved in 
THF (1 mg/mL) with surfactant PS-PAA (5 mg/mL) was rapidly injected into deionized 
water (9 mL) under continuous sonication with a microtip-equipped probe sonicator 
(Branson, W-150) at a power output of 6 W for 30 s. After sonication for an additional 1 
min, THF was removed by nitrogen bubbling for 3 hours. The aqueous solution was filtered 
through a polyethersulfone (PES) syringe driven filter (0.22 µm) and centrifuged three 
times using a 30 K centrifugal filter unit at 3500 rpm for 15 min. PAN solution was stored 
in dark at 4 °C for further use. 
4.2.4 Photoacoustic signal measurement of PAN 
The PAN solution (1 mg/mL) was added into a polyurethane capillary tube with two 
ends fixed with Epoxy. A customized and compact passively Q-switched diode-pumped 
solid-state laser (1030 nm, 3 ns, 100 µJ, RPMC, Fallon, MO, USA) was used as the 
excitation source. The laser was connected to an optical fiber through a homemade fiber 
jumper (SMA-to-SC/PC, ~81% coupling efficiency). The laser driver was adjusted to set 
the output power from the fiber jumper to be approximately 55 mW. The capillary tube 




Olympus, Waltham, MA, USA) was mounted on a motorized rotation stage to record the 
optoacoustic signals across different angles. The ultrasonic signal was first amplified by an 
ultrasonic pre-amplifier (0.2–40 MHz, 40 dB gain, Model 5678, Olympus, Waltham, MA, 
USA) and then sent out to an oscilloscope (DSO6014A, Agilent Technologies, Santa Clara, 
CA, USA) to readout. The signal was averaged 20 times. All of the devices were 
synchronized by the output from the active monitoring photodiode inside the laser. 
4.2.5 Animals 
Embryonic day (E) 14−15 rats, obtained from female, pregnant Sprague−Dawley rats 
bred were used. All animal care was carried out in accordance with the National Institute 
of Health Guide for the Care and Use of Laboratory Animals (NIH Publications No. 80−23; 
revised 1996) and was operated under protocol 000197 approved by Boston University 
Animal Care and Use Committee. 
4.2.6 Embryonic neuron culture  
The glass-bottom culture dishes used in the embryonic neuron cell cultures were 
immersed in 0.01% Poly- D-Lysine (Sigma-Aldrich, MO) for overnight at 4 °C and washed 
in PBS before culture initiation. Primary spinal cord neurons were obtained from SD rat 
E15 embryos. The spinal cords were isolated and placed in the L15 medium. Meninges 
were removed and spinal cords were cut into small pieces, dissociated by incubation in 
0.05% trypsin/ethylenediaminetetraacetic acid (EDTA, VWR, PA) 15 min at 37 °C and 
triturated every 5 min. Dissociated cells were washed with and triturated in 10% heat-




serum (HS, Atlanta Biologicals, GA), 2 mM Glutamine-Dulbecco’s Modified Eagle 
Medium (DMEM, Thermo Fisher Scientific Inc., MA), and cultured in cell culture dishes 
(100 mm diameter) for 30 min at 37 °C to eliminate glial cells and fibroblasts. The 
supernatant containing neurons was collected and seeded on poly-D-lysine coated cover 
glass and incubated in a humidified atmosphere containing 5% CO2 at 37 °C with 10% 
FBS + 5% HS + 2 mM glutamine DMEM. After 16 h, the medium was replaced with 
Neurobasal medium (Thermo Fisher Scientific Inc., MA) containing 2% B27 (Thermo 
Fisher Scientific Inc., MA), 1% N2 (Thermo Fisher Scientific Inc., MA), and 2 mM 
glutamine (Thermo Fisher Scientific Inc., MA).  
4.2.7 TA microscopy 
TA images were obtained as previously described [215-216]. For each TA image, the Z 
position of the focus was adjusted near the equatorial plane of the neurons so that the soma 
and neurites were both clearly visualized. The pump (845 nm) and Stokes (1045 nm) 
powers before the microscope were maintained at 20 and 20 mW, respectively. Both the 
pump and Stokes beams were linearly polarized. No cell or tissue damage was observed. 
Images were acquired at 2 µs pixel dwell time.  
To quantify the number of PANs that bind onto neurons, the following estimation was 
used. A concentration of PAN can be calculated based on the calibration curve from TA 
images. The volume of the focal spot on a signal neuron was estimated based on the area 
on the neuronal soma (measured from ImageJ) and depth of 1 mm. The molecular weights 




kD and 125 kD.  
4.2.8 SEM imaging of PAN on neurons 
Cells were fixed in glutaraldehyde solution and then rinsed three times in phosphate-
buffered saline (PBS, VWR, PA). Subsequently, samples were immersed in OsO4 (Sigma-
Aldrich, MO) for 40 min and then rinsed 3 times in PBS, followed by dehydration. The 
dried samples were mounted on aluminum stubs and coated with platinum for imaging. 
4.2.9 Cytotoxicity tests 
Neurons were seeded in 96-well plates (1,000 cells/well in 100 µL) and incubated for 
7 days to become mature. PAN with a concentration of 20, 40, 60 µg/mL was added to the 
cell culture medium, respectively. Neurons were incubated with PAN or cell culture 
medium only for 1 hour and 24 hours, respectively. The medium was then removed and 
washed with PBS. MTT (20 µL, 5 mg/mL) was added to the wells, and plates were 
incubated for 5 h. The cell culture medium was then removed, and dimethylsulfoxide 
(DMSO, 200 µL) was subsequently added to each well. Finally, the plates were gently 
shaken for 10 min at room temperature to dissolve all formed precipitates. The absorbance 
of MTT at 590 nm was measured using a SpectraMax plate reader. Cell viability was 
expressed as the ratio of the absorbance of the cells incubated with PAN to that of control 
cells. 
4.2.10 Bioconjugation of PAN-TRPV4 




NHS (30 µL, 9 mg/mL) and EDC (50 µL, 9 mg/mL). The mixture was stirred for 1 hour at 
room temperature in a brown glass bottle. Anti-TRPV4 antibody (5 µL, 1 mg/mL) was 
added into the mixture and kept stirring at room temperature overnight. The resulted 
solution was filtered again through a polyethersulfone (PES) syringe driven filter (0.22 
µm) and centrifuged three times using a 50 K centrifugal filter unit at 3500 rpm for 15 min. 
PAN-TRPV4 solution was stored in dark at 4 °C for further use.  
4.2.11 Agarose gel electrophoresis 
Agarose gel (0.5 %) were prepared using agarose power purchased from Bio-Rad 
(Certified Molecular Biology Agarose) and immersed in 1× Tris/boric acid/EDTA (TBE) 
buffer with 0.1% sodium dodecyl sulfate (SDS). The PAN and PAN-TRPV4 solution (0.1 
mg/mL, 10 µL) mixed with SDS (1 µL, 10%) was loaded into the wells of the gel. The 
electrophoresis process was operated on a horizontal electrophoresis system (Mini-Sub 
Cell GT; electrode spacing 15 cm) for 1 h at 150 V. The location of nanoparticles was 
imaged on a white lightbox with a digital camera (Sony α7). 
4.2.12 Immunofluorescence imaging 
Cells were fixed with 4% paraformaldehyde for 20 min. After 3 washes, cells were 
blocked in 5% bovine serum albumin (Sigma-Aldrich, MO) for 30 min and permeabilized 
with 0.2% Triton X-100 (Sigma-Aldrich, MO). Then cells were incubated with mouse 
monoclonal anti-TRPV4 (1:1000) antibody for 2 h, and then with goat anti-mouse 
secondary antibody (1:1000, 488 nm, Thermo Fisher Scientific Inc., MA) for 1 h at room 




fluorescence microscope (Olympus). 
4.2.13 In vitro optoacoustic neurostimulation 
PAN and PAN-TRPV4 (150 µL, 20 µg/mL) was added into the culture medium of 
GCaMP6f labeled neurons to reach a final concentration of 2 µg/mL. An incubation time 
of 15 minutes and 1 hour was tested. A 1030-nm nanosecond laser was delivered onto the 
cells using the setup we described in the optoacoustic signal measurement section. For 
the CW laser, Cobolt Rumba 1064 nm 500 mW laser was used. The CW laser was gated 
with a mechanical shutter to deliver a laser pulse with a duration of 3.9 ms. The images 
were recorded using a CCD camera (model number) mounted together with home-built 
wide-filed fluorescence microscopy (Olympus) The fluorescence intensities were 
analyzed using ImageJ (Fiji). 
4.2.14 In vivo injection of PAN 
Adult (age 14-16 weeks) C57BL/6J mice were used. Mice were initially anesthetized 
using 5% isoflurane in oxygen and then placed on a standard stereotaxic frame, maintained 
with 1.5 to 2 % isoflurane. Toe pinch was used to determine the level of anesthesia 
throughout the experiments and body temperature was maintained with a heating pad. The 
hair and skin on the dorsal surface targeted brain regions were trimmed. Craniotomies were 
made on primary somatosensory (S1) (AP -1.34 ML 2.25) and primary auditory cortex 
(A1) (AP -2.46 ML 4.25) based on stereotaxic coordinates using a dental drill and artificial 
cortical spinal fluid was administrated to immerse the brain. After stimulation and 




removed and sectioned for histology.  
4.2.15 In vivo optoacoustic neurostimulation 
Electrophysiology was performed using tungsten microelectrodes (0.5 to 1 MΩ; 
Microprobes). Tungsten microelectrodes were driven to recording sites through cranial 
windows (d = 1.5 mm) based on stereotactic coordinates and confirmed by 
electrophysiological signatures. The electrodes were positioned with a micromanipulator 
(Siskiyou). Extracellular recordings were acquired using a Multi-Clamp 700B amplifier 
(Molecular Devices), filtered at 0.1 to 100 Hz, and digitized with an Axon DigiData 1550 
digitizer (Molecular Devices). For calculation of response latency, the pre-stimulation 
period in each recording was used to obtain baseline mean and SD. The threshold was 
determined by mean ± 2*SD. The latency was determined when the voltage crosses the 
threshold for the first time. 
4.2.16 Data analysis 
Calcium images were analyzed using ImageJ. Calcium traces, electrophysiological 
traces, and EMG recordings were analyzed using Origin. Data shown are mean ± SD. 
 
4.3 Surface modification of PAN can generate acoustic waves under NIR-II light. 
We first  synthesized thienoisoindigo (TII) based semiconducting polymers (SPs) with 
triethylene glycol side-chains (TII-TEG) attached onto the backbone [212]. As we reported 




the NIR-II window [212]. We then modified SPs with polystyrene-block-poly(acryl acid) 
(PS-b-PAA) as the surfactant via the nanoprecipitation method to synthesize 
semiconducting polymer nanotransducers (PANs) (Figure 4.3). The PS-b-PAA was 
chosen here due to the amphiphilic nature of its chemical structure. The hydrophobic 
polystyrene portion can form a π-π stacking with the polymer, while the hydrophilic 
poly(acryl acid) (PAA) makes the polymer into water-soluble PANs with carboxyl groups 
decorated on the surface of PANs.  
 
Figure 4.3. Schematic of the PAN synthesis process. 
 
FT-IR spectrum confirmed the presence of carboxyl groups on PAN (Figure 4.4a), 
indicating the successful modification. The diameter of PANs was measured to be 58.0 ± 
5.2 nm using dynamic light scattering (DLS) (Figure 4.4b). To confirm that PS-b-PAA 





(DSPE-PEG(2000)) as a control group. Measured by zeta potential measurement, PS-b-
PAA modified PANs were found to be negatively charged with surface charge indicated 
by a potential of -79.79 ± 4.04 mV and DSPE-PEG(2000) modified SPs are charged with 
- 4.88 ± 3.06 mV (Figure 4.4c). Then, we studied the optical and optoacoustic properties 
of PANs. As confirmed by Ultraviolet (UV)-Visible-NIR spectrum, PANs absorb broadly 
NIR-II light from 800 to 1300 nm with a peak at 1100 nm (Figure 4.4d). Measured with 
an ultrasound transducer with a central frequency at 5 MHz, PAN solution (1 mg/mL) 
showed a typical photoacoustic signal with a peak to peak amplitude of 33.95 mV (Figure 
4.4e) under 1030 nm nanosecond laser. Therefore, the as-synthesized PAN was 





Figure 4.4. Characterization of PAN. (a) FTIR spectrum of PAN modified by PS-PAA. (b) 
Dynamic light scattering analysis of PAN solution. (c) Zeta potential measurement of the PAN 
solution. (d) UV-Vis spectrum of the PAN solution. (e) Optoacoustic signal measurement of the 




4.4 Negatively charged PANs can sufficiently bind to neuron. 
As recently reported, nanoparticles with negatively charged surface can bind onto 
neuronal membrane, whereas positive and neutral nanostructures showed no interactions 
with neurons [217]. Here, to examine whether negatively charged PANs can bind onto the 
neuron membrane, we cultured PANs with embryonic cortical neurons collected from E14-
16 Sprague Dawley (SD) rats. The neurons were cultured for 15-18 days (Days in vitro, 
DIV15-18). 150 µL 20 µg/mL PAN solution was added into the culture medium to reach a 
final concentration of 2 µg/mL. We kept this condition the same throughout our 
experiments. PAN was previously shown to have strong intensive intrinsic transient 
absorption (TA) signals. Label free TA microscopy was then used to visualize PAN on 
neurons [218-219]. Specifically, we used 200 fs laser pulses at 845 nm and 1045 nm as pump 
and probe beams, respectively, with a laser power fixed at 20 mW for both beams for TA 
imaging. To quantify the effective concentration of PANs bound to neuron, we measured 
the signal-to-noise ratio (SNR) of the TA signals of PAN standard solutions with 
concentrations ranging from 2.0 to 55.0 µg/mL to obtain a calibration curve. The SNR of 
TA signals was found to be linear to the PAN concentration with a slope of 14.24 
(R2=0.9878) (Figure 4.5). The detection limit of the TA microscopy was found to be ~0.14 





Figure 4.5. TA microscopy for imaging PAN solution. (a)TA imaging of PAN solution with 
concentration range in 2.0 to 55.0 µg/mL. (b) TA signal-to-noise ratio (SNR) plotted against 
concentration of PAN solution. Date were fitted linearly.  
 
Being able to control and quantify the binding density of PAN to neurons is critical for 




rinsed three times with PBS and fixed the cells for TA imaging. All the unbound PANs 
were expected to be removed during the rinsing process. With 15 minutes incubation, 
PANs were found to bind onto the soma area of the neurons and to show a density of 40.2 
± 15.9 PANs per neuron (Figure 4.6a). The number of PAN was calculated based on TA 
intensity, focused spot volume and estimated molecular weight of PAN. Scanning electron 
microscope (SEM) images also indicated the presence of PANs on the embryonic neuron 
cells (Figure 4.6b). By increasing the culture time to 1 hour, a higher binding density was 
achieved. The binding number of PAN per neuron along the soma area was increased to 
78.1 ± 26.7 PANs/neuron (Figure 4.6c and e). It’s also worth noticing that, with longer 
culture time, PANs also started to accumulate along the neurites when soma area was fully 
covered. However, as a comparison, no PAN binds to the glial cells with 1-hour culture 
(Figure 4.6d).  To test the cytotoxicity of PAN, MTT assay was applied on neuron cells 
cultured with PAN for 1 hour and 24 hours. High cell viabilities over 80% were observed 
in all experimental groups with PAN concentration ranging from 20 to 60 µg/mL (Figure 
1f), indicating high biocompatibilities and low cytotoxicity of PANs to neurons. All these 
results show that negatively charged PANs can sufficiently and selectively bind onto 






Figure 4.6. Surface modified PAN and confirmation of neuronal binding via transient 
absorption (TA) microscopy. (a) TA images of PAN binding to neurons in 15 minutes. Scale bar: 
50 µm. (b) SEM images of the binding of PAN to neurons. Scale bar: 2 µm. (c,d) TA images of 
PAN cultured with neurons (c) and glial cells (d) for 1 hour. Scale bar: 50 µm. (e) Binding density 
analysis of PAN to neurons and glial cells at 15 minutes and 1 hour, respectively. (f) Cytotoxicity 




4.5 PAN mediated optoacoustic neural stimulation. 
We further investigated optoacoustic neuron stimulation through bound PANs. To 
confirm the neural activations, we transfected the primary cortical neurons (DIV 5) with 
GCaMP6f, cultured for 10–14 days and performed Calcium imaging with a widefield 
fluorescence microscope with excitation wavelength of 488 nm (Figure 4.7a). Neuron 
cultures (DIV 15-18) were cultured with PAN solution (150 µL, 20 µg/mL) in the culture 
medium to reach a final concentration of 2 µg/mL. After incubated for 15 minutes, 
nanosecond laser at 1030 nm was delivered via a 200 µm diameter optical fiber. Conditions 
of the pulsed laser include a pulse width of 3 ns, a repetition rate of 3.3 kHz, a laser duration 
of 3 ms (corresponding to 10 laser pulses) and an energy density of 21 mJ/cm2. 
Measurements and analysis of fluorescence signal change were collected from total 60 
neurons from 5 culture batches, within 100 µm proximity with respect to the position of 
the fiber were performed.  
More than 80% of the neurons illuminated by the pulsed laser showed strong responses 
to the stimulation, demonstrated by the fluorescent intensity change in Figure 4.7b. 
Increases in fluorescence intensity of GCaMP6f at individual neurons (which neurons in 
the view field) were clearly observed immediately after applying the nanosecond laser for 
3ms at recording time of 5s. Out of total 60 neurons studied; 51 neurons show a substantial 
fluorescence increase F/F0 ratio with a minimal above 1.1 (10% signal increase) after the 
laser onset (Figure 4.7b), in which F0 is the baseline fluorescence signal of the neurons 
before the stimulation. Notably, two different types of response curves were detected, a 




baseline (representative curves are shown in Figure 4.7c and d). Specifically, we defined 
a time constant when the response curves exponentially decay from the peak fluorescence 
intensity to its 36%. The transient activations typically show decay time constants in a 
range of 2-5s, while the prolonged activations have time constants ranging in 5-10s.  
A success rate, defined as the percentage of activated neurons, which show F/F0 ratio 
above 1.1 was calculated and used to measure the efficiency of optoacoustic stimulation 
through PAN. Under the 3 ms laser duration, total 85.0% of the neurons exhibited 
synchronized activations immediately after the nanosecond laser is on-set. Specifically, 
15.0 ± 10.0% of transient stimulations and 70.0 ± 21.8 % of prolonged activations were 
observed, respectively (Figure 4.7e). 
 To verify the observed activation based on the increase fluorescence intensity is due 
to activation potential activation, we performed a control with addition of 3µM of 
Tetrodotoxin (TTX). With the addition of TTX, only total of 7% neurons showed 
activation, with 1.7 ± 2.9% for transient activation and 5.0 ± 5.0 % for prolonged activation 
(Figure 4.7f). Additionally, a control of only applying nanosecond laser at the same 
condition but without PAN was also performed.  Activation with a success rate of 1.7 ± 
2.9% for prolonged activation were found, indicating optical excitation through laser alone 
is not triggering the activities. We further applied a cocktail of synaptic receptor blockers 
(10 µM NBQX, 10 µM Gabazine and 50 µM DL-AP5) [220], to study the networking effect 
in activation. As shown in Figure 4.7g, application of synaptic blockers significantly 
reduces the success rate of PAN activation to 8.3 ± 5.8% for the transient activation. This 




by synaptic inputs from a subpopulation of neurons directly stimulated initially by PAN. 
Particularly, the prolonged activation is completely blocked, with a success rate decreased 
to 0%, indicating that prolonged response is likely due to accumulated activation 
contributed by the network of neurons. Collectively, we have confirmed the observed 





Figure 4.7. PAN induced neurostimulation with over 80% success rate. (a) Representative 




minutes. Scale bar: 100 µm. White dash line indicates the position of the optical fiber. (b) Colormap 
of fluorescence signal change of neurons stimulated by a 1030 nm nanosecond laser with 3 ms laser 
duration of 10 pulses.  (c,d) Averaged response curves of transient stimulation (c) and prolonged 
stimulation (d). (e-g) Colormaps of fluorescence signal changes of neurons treated with laser only 
(e), with TTX added into the culture medium (f) and with synaptic blocker cocktail added in the 
culture medium with nanosecond laser with 3 ms laser duration of 10 pulses, respectively. All 
Colormaps were plotted under same dynamic range. (h) Success rate (the ratio of stimulated 
neurons to total neuron cell number) analysis.  
 
Key parameters to control and to vary the stimulation through PAN include laser 
conditions and binding density of PAN on neurons. To obtain quantified insight on what 
are the necessary and/or optimized conditions allowing successful optoacoustic activation 
by PAN, we first studied the effect on activation by increasing the laser duration to 5 and 
10 ms, corresponding to the number of laser pulses from 17 to 33, respectively. In the laser 
only groups, the overall success rate was found to be 3.3 ± 2.0% using 5 ms, and 18.3 ± 
10.4% for 10 ms (N=60, 3 different culture batches), dominated by the prolonged activation 
(Figure 4.8 a-c). With the presence of PAN from a 15 min culture with neurons, under the 
5 ms laser duration, an overall success rate of 66.7 ± 14.4% was achieved (N=60, 3 different 
culture batches), show no significant difference with 3 ms. When laser duration was 
increased to 10 ms, the success rate was found to be 80.0 ± 15.3 % (Figure 4.8 d-f). It was 
noticed that the laser duration of longer than 3ms will produce neural activities dominated 
by prolonged activation. Therefore, 3 ms is the optimal laser duration for neurostimulation 






Figure 4.8. Neuromodulation rate as a function of laser duration. (a-b) Colormaps of 
fluorescence signal change of neurons stimulated by a 1030 nm nanosecond laser only with laser 
duration of 5 ms (16 pulses, a) and 10 ms (32 pulses, b), respectively. (c) Success rate of nanosecond 
laser induced neurostimulation. (d-e) Colormaps of fluorescence signal change of neurons cultured 
with PAN solution for 15 minutes and stimulated by a 1030 nm nanosecond laser only with laser 
duration of 5 ms (d) and 10 ms (e), respectively. (f) Success rate of PAN induced neurostimulation 
under different laser durations. All Colormaps were plotted under same dynamic range.  
 
To investigate how binding density might control PAN mediated stimulation, we chose 
to vary the culture time of PAN with neuron cultures. In the group when the stimulation 
was performed immediately after addition of PAN, no neural activation was detected 
(Figure 4.9a), indicating that only optoacoustic stimulation through PAN was localized 
and bound PANs can trigger the optoacoustic stimulation. In addition, in the group when  




for transient activations and 28.33 ± 16.07 % for prolonged activation were observed 
(Figure 4.9b and c), showing no significant difference compared with the results from the 
15 minutes culture, indicating 15 minutes culture time we used is sufficient enough to 
trigger neurostimulation.  
 
Figure 4.9. Neurostimulation rate as a function of culture time. Colormaps of fluorescence 
intensity change of no culture (a) and 1-hour culture of PAN (b). (c) Success rate analysis (c).  
 
4.6 PAN-mediated optoacoustic stimulation is distinct from photothermal 
stimulation. 
Continuous wave (CW) laser is known to produce a photothermal process with no 
generation of optoacoustic signal [221]. Therefore, by comparing the potential stimulation 
effect of PAN upon excitation of the CW laser  as the same condition to the results obtained 
from the nanosecond laser, we can determine how different our stimulation is from the 
known photothermal process and then obtain insights on how much the photothermal 
process might contribute to the success activation discussed above.  Since PAN absorb 




PAN bound to the neurons. Identical neuron and culture conditions were used, specifically 
neurons at DIV 15-18 were incubated with PAN with a final concentration of 2 µg/mL in 
the culture medium for 15 minutes.  
As shown in Figure 4.10a, no activation was detected with the power at 61 W/cm2, the 
same used by the nanosecond laser for optoacoustic stimulation in 3.9 ms laser duration 
(N=30, 3 different cell culture batches).  No activation was observed as we increased the 
laser power to 397 W/cm2 and kept 3.9 ms as the laser duration (N=30, 3 different cell 
culture batches, Figure 4.10b). Compared with CW laser, the nanosecond laser condition 
used to achieve successful activation is much milder, 61 W/cm2 and 3 ms, indicating that 
compared with photothermal methods, which relies on temperature accumulation, our 
method by using optoacoustic signals is more efficient. Significantly, the optoacoustic 
process triggered by nanosecond laser has much higher efficiency and contributed 
dominantly in the observed activation. 
 
Figure 4.10. Neural activation is not induced by photothermal effect. (a-c) Colormaps of 




laser with laser condition of (a) 3.9 ms laser duration with a power density of 61 W/cm2; (b) 3.9 
ms laser duration with a power density of 397 W/cm2 and (c) 2.5 s laser duration with a power 
density of 397 W/cm2. All Colormaps were plotted under same dynamic range.  
 
4.7 PAN-TRPV4 for more specific neurostimulation 
To enable a specific optoacoustic neurostimulation, we bioconjugated the PAN with 
antibodies to specifically target the mechanosensitive ion channel. Transient receptor 
potential cation channel subfamily V membrane 4 (TRPV4) is chosen here due to its high 
expression rate on the neuronal cell membranes and its capability in sensing external 
mechanical stimuli [222-223]. We conjugated PAN with anti-TRPV4 antibody through a 
carbodiimide coupling reaction between the carboxyl group on PAN to the amine group on 
the antibody (Figure 4.11a) [111]. We confirmed the success of the bioconjugation.  Using 
electrophoresis (Figure 4.11b), we confirmed that PAN-TRPV4 migrated much less 
compared with PAN. A size increase from 59.4 ± 5.3 nm to 181.8 ± 36.7 nm was revealed 
by DLS analysis (Figure 4.11c). The zeta potential became almost neural for PAN-TRPV4, 





Figure 4.11. Characterization of bioconjugated PAN. (a) Schematic of the synthesis process 
of bioconjugated PAN-TRPV4. (b) Electrophoresis measurements of PAN and PAN-TRPV4 
solutions. (c) DLS analysis of PAN and PAN-TRPV4 solutions. (d) Zeta potential measurement of 
PAN and PAN-TRPV4 solutions. 
 
No color change was noticed in the PAN-TRPV4 solution (Figure 4.12e). No obvious 





Figure 4.12. Digital images of PAN and PAN-TRPV4 solutions with concentration of 20 
µg/mL (a). Normalized UV-Vis spectrum of PAN and PAN-TRPV4 solution (b). 
 
To test the cellular binding of PAN-TRPV4 to neurons, we first confirmed the 
expression rate of the TRPV4 channel in the membrane of embryonic cortical neurons. As 
indicated in IF staining images (Figure 4.13a), TRPV4 channels are expressed vigorously 
throughout the soma and neurites of the neurons, as expected [224-225], indicating that a high 
expression rate of binding sites to PAN-TRPV4 are available on the neuronal membrane 
for possible binding. By adopting the same cell culture condition, we applied TA 
microscopy to locate PAN-TRPV4 on neurons. Shown in Figure 4.13b, a larger binding 
density was observed for PAN-TRPV4 with a density of 43.8 ± 20.8 per soma, compared 





Figure 4.13. PAN-TRPV4 binding process to neurons. (a) IF images of TRPV4 channel 
expression on the neuron membrane labeled with anti-TRPV4 antibody. (b) TA images of PAN-
TRPV4 cultured with neurons for 15 minutes. Scale bar: 50 µm. 
 
Then, we studied whether the bioconjugated PAN-TRPV4 will result in different neural 
response and improve the performance of neural stimulation through direct binding to the 
mechanosensitive ion channels. Under the same experimental condition used for PAN, we 
analyzed 60 neurons collected from 5 different culture batches to statistically quantify the 
neurostimulation. As shown in Figure 4.14a, neural activations induced by the 
photoacoustic signals produced by PAN-TRPV4 show an overall success rate of 55.0%, of 
which the transient stimulation responses shows a 50.0 ± 5.0% and the prolonged response 
shows a 5.0 ± 5.0 %. The portion of transient activation increased substantially, compared 
to that for PAN. As shown in Figure 4.14b, with synaptic blockers in the culture medium, 
the overall success rate remains as 53.3%. 51.7 ± 12.6 % of neurons showed transient 
activation and only 1.7 ± 2.9 % showed prolonged activation, which indicates the transient 




To further validate the observed activation is mediated by the activation of the TRPV4 
channel, we added a specific TRPV4 channel blocker, GSK 2193874 [226], into the cell 
culture, prior to adding PAN-TRPV4 solution (N=30, collected from 3 different culture 
batches). As shown in Figure 4.14 c,d, with the presence of TRPV4 channel blockers, the 
success rate was significantly reduced, with 10.0 ± 10.0% of the neurons showing transient 
stimulation and no prolonged activation was detected.  These results collectively confirmed 
that PAN-TRPV4 enabled a specific stimulation directly to the TRPV4 ion channel to 
modulate neuroactivities. 
 
Figure 4.14. Bioconjugated PAN increases specific neurostimulation. (a-c) Colormaps of 
fluorescence signal change of neurons treated with PAN-TRPV4 without synaptic blocker (a), PAN 




added in the culture medium (c) with nanosecond laser with 3 ms laser duration of 10 pulses, 
respectively. (d) Success rate analysis.  
 
4.8 In vivo optoacoustic neurostimulation by PAN.  
To further validate the optoacoustic neurostimulation in vivo, we directly injected PAN 
solution into the primary motor cortex of C57BL/6 mice. To validate PAN mediated 
stimulation in vivo, we performed local field potential recording on the PAN injection site 
following injection. To avoid electric artifact produced by laser radiation on the metal 
recording electrode, we used multifunctional fibers with conductive polymer coating as the 
recording electrods (Figure 4.15) [227-228], which eliminated the laser artifact.  
 
 
Figure 4.15. Cross-section images of multifunctional fibers used for neural electrical 




The 600 nl of PAN solution at concentration 1.0 mg/mL was allowed to diffuse and 
stabilize for 1 hr (Figure 4.16a). As shown in the Figure 4.16b, c, 3 ms laser pulse train 
at 70 mW produces strong LFP response on the stimulated cortex, while in the control 
group without PAN injection, the laser did not produce any response. After establishing 
the feasibility of PAN stimulation in vivo, we next turn to evaluate the behavior outcome 
of the stimulation. We performed electromyography (EMG) as an indirect measurement of 
the effect of PAN stimulation. The 600 nl of PAN at 1.0 mg/mL was delivered to the 
primary motor cortex of the mouse. After 1 hr diffusion, a needle electrode was inserted 
subcutaneously and parallel to the forelimb triceps brachii muscle. A reference electrode 
was inserted in the footpad with a ground electrode was inserted subcutaneously on the 
trunk and ipsilateral to the stimulation site (Figure 4.16d). 200 ms laser pulse train were 
delivered the injection site through the optical fiber, and EMG responses with an amplitude 
of 428.8 ± 119.0 µV, and a delay of 127.8 ± 24.3 ms was recorded (Figure 4.16e). These 
results suggest that the PAN mediated stimulation was sufficient to induce motor cortex 





Figure 4.16. In vivo neurostimulation by directly injected PAN. (a) Schematic of in vivo 
experiment procedures. (b) Fixed brain slice after in vivo experiment. (c) TA images taken at 
location 1, 2 and 3 in b. Red, TA signals from PAN. Scale bar: 100 µm. (d) Schematic of in vivo 
electrophysiology measurement. (e) Representative curves of electrophysiology measured in the 
region without PAN as the control group and PAN treated region on 3 mice. (f) Schematic of EMG 






In summary, we successfully demonstrated optoacoustic neural stimulation by 
semiconducting polymer nanotransducers both in vitro and in vivo.  
Photothermal effect of Au nanoparticles was previously found to be able to provide 
neural stimulation in vitro. In these photothermal processes, absorption of light was 
converted to an increase of absolute temperature, with a suggested threshold of 43 °C for 
successful neural stimulation. Notably, we confirmed that under the same laser duration 
and power condition, CW laser-induced photothermal effect through PAN failed to induce 
neural activities. This finding provides direct evidence supporting that, by only relying on 
the temperature increase, the photothermal neurostimulation is less efficient than the 
optoacoustic effect induced by PAN. In addition, it has come to our attention that fast 
temperature ramping resulted from a rapid laser pulse energy change within a short time 
period can also induce membrane capacitive current change to enable neurostimulation 
[229]. Similar mechanism has been established on infrared neuron stimulation [230-231]. 
Indeed, for the optoacoustic effects, it is impossible to decouple the acoustic effect from 
thermal effect. However, for our case, since we are using nanosecond laser, we believe the 
temperature change profiles are significantly different from the conditions that used for 
CW laser and femtosecond laser with a laser pulse width from 1 µs to millisecond level. 
Based on theoretical studies on the photoacoustic mechanism of PAN [232], the temperature 
change induced by a single nanosecond laser pulse or a few pulses, can be quickly 
generated and dissipated in a few nanoseconds. Therefore, it is a totally different time scale 




underlies different mechanism compared with their opto-capacitive generation of action 
potentials, which is dominated by optoacoustic process. 
It was also interesting that transient and prolonged responses were observed in PAN 
and PAN-TRPV4 mediated stimulation: the transient and prolonged activations. We 
hypothesize that the transient activations are induced by single action potentials, while the 
prolonged activations are persistent activation of neurons with multiple action potentials, 
partly contributed by the neuronal network. We note that similar prolonged activations 
were observed in magnetic nanoparticle-mediated magneto thermal stimulation [114], and 
PAN-mediated photothermal stimulation [111], yet no transient activation was reported. It is 
likely that the temporal resolution of heating and thermal diffusion process in these works 
are much lower compared to the optoacoustic process, where only long and persistent 
activations were achieved. 
Another uniqueness of this work is the use of NIR-II light. Compared to magnetic field 
based neurostimulation [114-115], lights can be easily focused to enable high spatial resolution 
approaching diffraction limits for studying single neuron activities. In addition, NIR-II 
light has been reported to have enhanced penetration depth, up to 5 cm chicken breasts 
tissue [212] and other highly scattering medium[233-234], due to the low water absorption. Such 
capabilities promise the potential of a minimally invasive transcranial stimulation by using 
PAN. Therefore, the optoacoustic neurostimulation enabled by PAN at NIR-II window 






In all, we have achieved neurostimulation, dominated by optoacoustic signals, by 
semiconducting polymer nanotransducers with a success rate over 80%. The optoacoustic 
signal is enabled by nanosecond pulsed laser with NIR-II light at 1030 nm, which promises 
a high penetration depth. The stimulation was proved to show high temporal resolution 
within 10 laser pulses at 3 ms laser duration and high spatial resolution within 500 µm 
controlled by the diameter of the optical fiber tip. Utilizing the bioconjugation method, the 
efficiency of the single-cell stimulation was highly increased. In vivo stimulation was also 
achieved by directly injecting PAN to the mouse cortex. Therefore, the optoacoustic 
neurostimulation enabled by PAN at NIR-II window promises a new approach of 





CHAPTER 5: Outlook 
In this dissertation, we have focused on developing nano-bio interfaces for modulating 
cellular activities, mainly on neuronal cells. We have demonstrated that the presents of 
nanostructures can provide a positive impact on multiple neuronal activities, specifically 
regeneration and stimulation. Considering the fact that regeneration always comes together 
with stimulation for functional recoveries for the disease treatment, it is also meaningful 
and initiative to couple those two functional of nanostructures together in the platform that 
is designed for disease treatment, especially for the SCI treatment, potentially functional 
regeneration in other tissue environments, such as bone, muscle, and tendons.  
5.1 3D scaffold for neuronal regeneration after SCI.  
To apply current 3D silk rolls for, in vivo application towards SCI, there are still some 
unsolved problems:  
As discussed in the in vivo experiment, the center hole in the current silk rolls causes 
undesired space to accumulate blood and dead cells that attract macrophage, which induces 
inflammation that stops axons to grow in. However, due to the self-folding method, the 
empty space is unavoidable in current systems. A potential method to address this issue 
can be using some hydrogels as the interspace filler to occupy the empty spaces in the silk 
rolls. These hydrogels should have low viscosity, so it can be absorbed into silk rolls. These 
hydrogels should also have enough stabilities and stiffness after the crosslinking, so the 
hydrogels can stay in the silk roll during the implantation process. Additionally, these 




the purpose of adding hydrogels is only to serve as a place holder for the regenerated axons, 
the hydrogels should start to slowly degrade after the implantation and be completely gone 
after the axons attached to the grafts.  
The second issue that needs to be addressed is how to create a better environment in 
the silk rolls that can promote axon regeneration. Adding growth factors into the silk rolls 
can a good way to go. Since the biodegradation speed of silk can be very well controlled 
by tuning the annealing methods and/or adding enzymes, neurotrophic growth factors, such 
as GDNF, NFG, and NT-3, can be added into the silk rolls to establish a slow-release 
system during the regeneration process. Having a slow and long term release of growth 
factors throughout the regeneration process has been proven to be effective for axonal 
regeneration after SCI [235]. More interestingly, since each growth factor has different 
functions and is prone to different stages during the regeneration, it is also meaningful to 
design a programmable sequence to release growth factors. Also, creating a gradient in the 
silk rolls are also potentially promote axon regeneration to cross the injured site.  
The third remaining questions are how to make a good interface between host tissue to 
the silk roll graft. Although patterned silk rolls showed improvement in guiding 
regenerated axons to grow into the scaffold, more designs are still needed to solve the 
interfacing issue. One possible way is to tune the mechanical properties of silk rolls, also 





5.2 Innervated and vascularized bone regeneration.  
Besides interaction within one type of cell itself, the communication between different 
cell types is also important for maintaining tissue functions. For example, the well-
functioned human bone is a fully vascularized and innervated system [236-237]. Blood vessels 
and nerve fibers are dynamically interacted with bone tissue, supplying oxygen and 
nutrients, and facilitating functional signaling during the bone development and healing 
process [238]. However, after an injury in the area of the large defects, the ordered network 
of blood vessel and nerves are commonly destroyed. Failure to restore the blood vessel 
system can result in a slow recovery process. Also, failure to rebuild the neural network 
can cause loss of sensory and, in most cases, chronic pain in the injured site [239]. Therefore, 
the lack of attention to the vascular and nervous networks could be one of the main reasons 
for the delayed and impaired recovery of bone fractures, especially in the large defect area. 
From this point of view, utilizing a cellular modulation process to regulate the activities of 
multiple cellular systems is also important in restoring functional recoveries in a tissue 
environment. 
Silk roll has outstanding advantages to be used to culture multiple types of cells within 
a confined location. Its application should not only be limited in the SCI treatment. The 
heterogeneous cell culture we discussed in Chapter 3 is a good example. The silk rolls 
developed here can be a good platform to mimic the bone structure and for the tendon 





5.3 Stimulable scaffold for tissue regeneration.  
During the SCI treatment process, connections between the host tissue and descending 
targets have been blocked. Since we have demonstrated that photoacoustic nanotransducers 
can stimulate neurons, there could be a potential application to couple PANs with silk rolls 
to enable s stimulable scaffold. External light will be delivered to the scaffold to activate 
regenerated neurons. Two possible functionals can be achieved: (1) Serving as a temporal 
rally station to conduct signals; (2) stimulation can promote the regeneration of neurons 
and generate more synaptic formation to recreate the networking between neurons.  
Another of the possible applications is to achieve respiratory control during or after 
SCI. Cervical contusion SCI results in reduced phrenic motor output and attenuated phrenic 
motor responses, which leads to respiratory challenge. Currently, invasive electrodes used 
as diaphragm pacer is the only effective way to control the breathing issue of SCI patients. 
However, its functions and outcomes are limited by sophisticated surgical manipulations. 
Additional surgeries are needed to implant and also remove the electrodes. Inspired by this 
problem, PAN coupled silk rolls can be a promising candidate to solve this issue. It can be 
implanted into the injured site of the cervical SCI model. The activities of the phrenic nerve 
can be controlled by the photoacoustic waves excited by external light stimulation, while 
the silk rolls can promote the regeneration process after SCI. Due to the high 
biocompatibility and controllable biodegradation speed of silk, no removal surgery is 
needed here. Therefore, the invasiveness of current electrodes-based diaphragm pacers can 




stimulable scaffold, more other possibilities are pending exploration. But I personally 







APPENDIX: NeuronJ for measuring neurite length 




final class Segment { 
  
 private int iCapacity = 500; 
 private final int iCapInc = 500; 
 private int iSize = 0; 
 private Point[] parray = null; 
  
 Segment() { 
  parray = new Point[iCapacity]; 
 } 
  
 Segment(final int capacity) { 
  iCapacity = capacity; 
  parray = new Point[iCapacity]; 
 } 
  
 void add(final Point point) { 
  if (iSize == iCapacity) inccap(); 
  parray[iSize++] = point; 
 } 
  
 private void inccap() { 
  iCapacity += iCapInc; 
  final Point[] newparray = new Point[iCapacity]; 
  for (int i=0; i<iSize; ++i) newparray[i] = parray[i]; 
  parray = newparray; 
 } 
  
 Point first() { return parray[0]; }-* 
  
 void first(final Point point) { parray[0] = point; } 
  
 Point last() { return parray[iSize-1]; } 
  
 void last(final Point point) { parray[iSize-1] = point; } 
  
 Point get(final int index) { return parray[index]; } 
  
 void get(final int index, final Point point) { 
  point.x = parray[index].x; 
  point.y = parray[index].y; 
 } 
  
 int nrpoints() { return iSize; } 
  
 void reset() { iSize = 0; }ci. 
  
 Segment duplicate() { 
  final Segment segment = new Segment(iCapacity); 
  segment.iSize = iSize; 




   segment.parray[i] = new Point(parray[i].x,parray[i].y); 
  return segment; 
 } 
  
 double length() { 
  double length = 0.0; 
  final double pw = NJ.calibrate ? NJ.imageplus.getCalibration().pixelWidth : 1; 
  final double ph = NJ.calibrate ? NJ.imageplus.getCalibration().pixelHeight : 1; 
  if (iSize > 1) for (int i=1; i<iSize; ++i) { 
   final double dx = (parray[i].x - parray[i-1].x)*pw; 
   final double dy = (parray[i].y - parray[i-1].y)*ph; 
   length += Math.sqrt(dx*dx + dy*dy); 
  } 
  return length; 
 } 
  
 double distance2(final Point point) { 
  double mindist2 = Double.MAX_VALUE; 
  // Minimum distance to vertices: 
  for (int i=0; i<iSize; ++i) { 
   final double dx = point.x - parray[i].x; 
   final double dy = point.y - parray[i].y; 
   final double dist2 = dx*dx + dy*dy; 
   if (dist2 < mindist2) mindist2 = dist2; 
  } 
  // Minimum distance to edges: 
  for (int i=1, im1=0; i<iSize; ++i, ++im1) { 
   final double v12x = parray[i].x - parray[im1].x; 
   final double v12y = parray[i].y - parray[im1].y; 
   final double v13x = point.x - parray[im1].x; 
   final double v13y = point.y - parray[im1].y; 
   final double inprod = v12x*v13x + v12y*v13y; 
   if (inprod >= 0.0f) { 
    final double v12len2 = v12x*v12x + v12y*v12y; 
    if (inprod <= v12len2) { 
     final double v13len2 = v13x*v13x + v13y*v13y; 
     final double dist2 = v13len2 - inprod*inprod/v12len2; 
     if (dist2 < mindist2) mindist2 = dist2; 
    } 
   } 
  } 
  return mindist2; 
 } 
  
 void values(final ByteProcessor bp, final Values values) { 
  final int ssfactor = NJ.interpolate ? NJ.subsamplefactor : 1; 
  for (int i=1, im1=0; i<iSize; ++i, ++im1) { 
   final double dx = (parray[i].x - parray[im1].x)/ssfactor; 
   final double dy = (parray[i].y - parray[im1].y)/ssfactor; 
   for (int j=0; j<ssfactor; ++j) { 
    final double x = parray[im1].x + j*dx; 
    final double y = parray[im1].y + j*dy; 
    values.add(bp.getInterpolatedValue(x,y)); 
   } 
  } 
 } 
  
 void reverse() { 




  for (int b=0, e=iSize-1; b<iHalf; ++b, --e) { 
   final Point tmp = parray[b]; parray[b] = parray[e]; parray[e] = tmp; 
  } 
 } 
  
 void draw(final Graphics g, final ImageCanvas imc, final Color color) { 
  final Rectangle vof = imc.getSrcRect(); 
  final double mag = imc.getMagnification(); 
  final int dx = (int)(mag/2.0); 
  final int dy = (int)(mag/2.0); 
  g.setColor(color); 
  if (iSize > 1) for (int i=1; i<iSize; ++i) { 
   g.drawLine( 
    dx + (int)((parray[i].x - vof.x)*mag), 
    dy + (int)((parray[i].y - vof.y)*mag), 
    dx + (int)((parray[i-1].x - vof.x)*mag), 
    dy + (int)((parray[i-1].y - vof.y)*mag) 
   ); 






final class Values { 
  
 private int capacity = 1000; 
 private final int capinc = 1000; 
 private int size = 0; 
 private double[] varray = new double[capacity]; 
 private double sum, mean, sd, min, max; 
  
 void add(final double value) { 
  if (size == capacity) inccap(); 
  varray[size++] = value; 
 } 
  
 private void inccap() { 
  capacity += capinc; 
  final double[] newarray = new double[capacity]; 
  for (int i=0; i<size; ++i) newarray[i] = varray[i]; 
  varray = newarray; 
 } 
  
 void reset() { size = 0; } 
  
 void stats() { 
   
  if (size == 0) { 
   sum = mean = sd = min = max = 0; 
  } else { 
   double val = 0; 
   sum = min = max = varray[0]; 
   for (int i=1; i<size; ++i) { 
    val = varray[i]; 
    sum += val; 
    if (val < min) min = val; 
    else if (val > max) max = val; 




   mean = sum/size; 
   double sumdev2 = 0; 
   for (int i=0; i<size; ++i) { 
    val = varray[i] - mean; 
    sumdev2 += val*val; 
   } 
   sd = Math.sqrt(sumdev2/(size-1)); 
  } 
 } 
  
 int count() { return size; } 
  
 double sum() { return sum; } 
  
 double mean() { return mean; } 
  
 double sd() { return sd; } 
  
 double min() { return min; } 
  





final class Dijkstra { 
  
 private final int INFINITE = 2147483647; 
 private final int PROCESSED = 2147483647; 
 private final int FREE = 2147483646; 
  
 private int[] ccost = null; 
 private int[] istat = null; 
 private byte[][] dirs = null; 
  
 byte[][] run(final float[][][] costvector, final Point startpoint) { 
   
  // Initialize variables and handles: 
  final float[][] costimage = costvector[0]; 
  final float[][] costfieldx = costvector[1]; 
  final float[][] costfieldy = costvector[2]; 
   
  final int iYSize = costimage.length; 
  final int iXSize = costimage[0].length; 
  final int iYSizem1 = iYSize - 1; 
  final int iXSizem1 = iXSize - 1; 
   
  final int iStartY = startpoint.y; 
  final int iStartX = startpoint.x; 
  if (iStartY <= 0 || iStartY >= iYSizem1 || iStartX <= 0 || iStartX >= iXSizem1) 
   throw new IllegalArgumentException("Starting point on or outside border of image"); 
  final int vstart = iStartY*iXSize + iStartX; 
   
  final int iNrPixels = iYSize*iXSize; 
  if (dirs == null || dirs.length != iYSize || dirs[0].length != iXSize) { 
   dirs = new byte[iYSize][iXSize]; 
   ccost = new int[iNrPixels]; 
   istat = new int[iNrPixels]; 




   
  // Mask border pixels and pixels outside window: 
  final int iXSizem2 = iXSize - 2; 
  final int iYSizem2 = iYSize - 2; 
  int iLX = 1; int iLY = 1; 
  int iHX = iXSizem2; int iHY = iYSizem2; 
  final int iHalfWinSize = NJ.dijkrange/2; 
  if (NJ.dijkrange < iXSizem2) { 
   iLX = iStartX - iHalfWinSize; 
   iHX = iStartX + iHalfWinSize; 
   if (iLX < 1) { iLX = 1; iHX = NJ.dijkrange; } 
   if (iHX > iXSizem2) { iHX = iXSizem2; iLX = iXSizem1 - NJ.dijkrange; } 
  } 
  if (NJ.dijkrange < iYSizem2) { 
   iLY = iStartY - iHalfWinSize; 
   iHY = iStartY + iHalfWinSize; 
   if (iLY < 1) { iLY = 1; iHY = NJ.dijkrange; } 
   if (iHY > iYSizem2) { iHY = iYSizem2; iLY = iYSizem1 - NJ.dijkrange; } 
  } 
  for (int y=0, i=0; y<iLY; ++y) 
   for (int x=0; x<iXSize; ++x, ++i) 
    { istat[i] = PROCESSED; dirs[y][x] = 0; } 
  for (int y=iHY+1, i=(iHY+1)*iXSize; y<iYSize; ++y) 
   for (int x=0; x<iXSize; ++x, ++i) 
    { istat[i] = PROCESSED; dirs[y][x] = 0; } 
  for (int y=iLY, i=iLY*iXSize; y<=iHY; ++y, i+=iXSize) { 
   for (int x=0, j=i; x<iLX; ++x, ++j) 
    { istat[j] = PROCESSED; dirs[y][x] = 0; } 
   for (int x=iHX+1, j=i+iHX+1; x<iXSize; ++x, ++j) 
    { istat[j] = PROCESSED; dirs[y][x] = 0; } 
  } 
   
  // Initialize arrays within window: 
  for (int y=iLY, i=iLY*iXSize; y<=iHY; ++y, i+=iXSize) 
   for (int x=iLX, j=i+iLX; x<=iHX; ++x, ++j) { 
    dirs[y][x] = 0; 
    ccost[j] = INFINITE; 
    istat[j] = FREE; 
   } 
   
  // Initialize queue: 
  final QueueElement[] queue = new QueueElement[256]; 
  for (int i=0; i<256; ++i) queue[i] = new QueueElement(); 
   
  // Define relative positions of neighboring points: 
  final int[] rpos = new int[9]; 
  rpos[8] = -iXSize - 1; 
  rpos[7] = -iXSize; 
  rpos[6] = -iXSize + 1; 
  rpos[5] = -1; 
  rpos[4] = 1; 
  rpos[3] = iXSize - 1; 
  rpos[2] = iXSize; 
  rpos[1] = iXSize + 1; 
  rpos[0] = 0; 
   
  // The following lines implement the shortest path algorithm as 
  // proposed by E. W. Dijkstra, A Note on Two Problems in 




  // pp. 269-271. Note, however, that this is a special 
  // implementation for discrete costs based on a circular queue. 
   
  // Initialization: 
  ccost[vstart] = 0; 
  int pindex = -1; 
  int cindex = 0; 
  queue[cindex].add(vstart); 
  boolean bQueue = true; 
   
  final float gamma = NJ.gamma; 
  final float invgamma = 1 - gamma; 
   
  // Path searching: 
  while (bQueue) { 
    
   final int vcurrent = queue[cindex].remove(); 
   istat[vcurrent] = PROCESSED; 
   final int iCY = vcurrent/iXSize; 
   final int iCX = vcurrent%iXSize; 
    
   for (int i=1; i<9; ++i) { 
    final int vneighbor = vcurrent + rpos[i]; 
    if (istat[vneighbor] != PROCESSED) { 
     final int iNY = vneighbor/iXSize; 
     final int iNX = vneighbor%iXSize; 
     float fDY = iNY - iCY; 
     float fDX = iNX - iCX; 
     final float fLen = (float)Math.sqrt(fDY*fDY + fDX*fDX); 
     fDY /= fLen; fDX /= fLen; 
     final int iCurCCost = ccost[vneighbor]; 
     final int iNewCCost = ccost[vcurrent] + 
     (int)(gamma*costimage[iNY][iNX] + 
      invgamma*127*(float)(Math.sqrt(1 - 
Math.abs(costfieldy[iCY][iCX]*fDY + costfieldx[iCY][iCX]*fDX)) + 
      Math.sqrt(1 - Math.abs(costfieldy[iNY][iNX]*fDY + 
costfieldx[iNY][iNX]*fDX)))); 
     if (iNewCCost < iCurCCost) { 
      ccost[vneighbor] = iNewCCost; 
      dirs[iNY][iNX] = (byte)i; 
      if (istat[vneighbor] == FREE) 
       istat[vneighbor] = queue[iNewCCost & 
255].add(vneighbor); 
      else { 
       final int iVIndex = iCurCCost & 255; 
       final int iEIndex = istat[vneighbor]; 
       queue[iVIndex].remove(iEIndex); 
       istat[queue[iVIndex].get(iEIndex)] = iEIndex; 
       istat[vneighbor] = queue[iNewCCost & 
255].add(vneighbor); 
      } 
     } 
    } 
   } 
    
   pindex = cindex; 
   while (queue[cindex].size() == 0) { 
    ++cindex; cindex &= 255; 




   } 
  } 
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